Document:

EX-4.1

 Exhibit 4.1 
  

 
 DISCOVER CARD EXECUTION NOTE TRUST

 Issuer 
 and 

U.S. BANK NATIONAL ASSOCIATION 

Indenture Trustee 
 CLASS
A(2014-2) TERMS DOCUMENT 
 Dated as of March 11, 2014 

to 
 AMENDED AND RESTATED
INDENTURE SUPPLEMENT 
 Dated as of June 4, 2010 

for the DiscoverSeries Notes 
 to

 INDENTURE 
 Dated as of
July 26, 2007 
  
  

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
	ARTICLE I	  
	
	Definitions and Other Provisions of General Application	  
			
	 Section 1.01
	 	Definitions	  	 	1	  
	 Section 1.02
	 	Representations and Warranties of Issuer	  	 	7	  
	 Section 1.03
	 	Representations and Warranties of Indenture Trustee	  	 	8	  
	 Section 1.04
	 	Limitations on Liability	  	 	8	  
	 Section 1.05
	 	Governing Law	  	 	8	  
	 Section 1.06
	 	Counterparts	  	 	8	  
	 Section 1.07
	 	Ratification of Indenture and Indenture Supplement	  	 	8	  
	
	ARTICLE II	  
	
	The Class A(2014-2) Notes	  
			
	 Section 2.01
	 	Creation and Designation	  	 	9	  
	 Section 2.02
	 	Adjustments to Required Subordinated Percentages and Amount	  	 	9	  
	 Section 2.03
	 	Interest Payment	  	 	9	  
	 Section 2.04
	 	Notification of LIBOR	  	 	10	  
	 Section 2.05
	 	Payments of Interest and Principal	  	 	10	  
	 Section 2.06
	 	Form of Delivery of Class A(2014-2) Notes; Depository; Denominations	  	 	10	  
	 Section 2.07
	 	Delivery and Payment for the Class A(2014-2) Notes	  	 	10	  
	 Section 2.08
	 	Targeted Deposits to the Accumulation Reserve Account	  	 	11	  
	 Section 2.09
	 	Additional Issuances of Notes	  	 	11	  
	 Section 2.10
	 	Investment of Funds in the Interest Funding Subaccount	  	 	12	  
	 Section 2.11
	 	Designation of Additional Amounts to be included in the Excess Spread Amount for the DiscoverSeries Notes	  	 	12	  
	 Section 2.12
	 	Variable Accumulation Period	  	 	12	  
	 Section 2.13
	 	Permitted Investments	  	 	13	  
	
	 Exhibit
	   

			
		 	 Exhibit
A                    Form of Class A
Note                                         
       
	  			

 THIS CLASS A(2014-2) TERMS DOCUMENT (this “Terms Document”), by and
between DISCOVER CARD EXECUTION NOTE TRUST, a statutory trust created under the laws of the State of Delaware (the “Issuer”), and U.S. BANK NATIONAL ASSOCIATION, a national banking association organized and existing under the laws
of the United States of America, as Indenture Trustee (the “Indenture Trustee”), is made and entered into as of March 11, 2014. 

Pursuant to this Terms Document, the Issuer shall create a new Tranche of Class A Notes of the DiscoverSeries and shall specify the
principal terms thereof. 
 ARTICLE I 

Definitions and Other Provisions of General Application 

Section 1.01 Definitions. For all purposes of this Terms Document, except as otherwise expressly provided or unless the context
otherwise requires: 
 (1) the terms defined in this Article have the meanings assigned to them in this Article, and include the plural as
well as the singular; 
 (2) all other terms used herein which are defined in the Indenture Supplement or the Indenture, either directly or
by reference therein, have the meanings assigned to them therein; 
 (3) all accounting terms not otherwise defined herein have the meanings
assigned to them in accordance with generally accepted accounting principles and, except as otherwise herein expressly provided, the term “generally accepted accounting principles” with respect to any computation required or permitted
hereunder means such accounting principles as are generally accepted in the United States of America at the date of such computation; 
 (4)
all references in this Terms Document to designated “Articles,” “Sections” and other subdivisions are to the designated Articles, Sections and other subdivisions of this Terms Document; the words “herein,”
“hereof” and “hereunder” and other words of similar import refer to this Terms Document as a whole and not to any particular Article, Section or other subdivision; 

(5) in the event that any term or provision contained herein shall conflict with or be inconsistent with any term or provision contained in the
Indenture Supplement or the Indenture, the terms and provisions of this Terms Document shall be controlling, but solely with respect to the Class A(2014-2) Notes; 

(6) each capitalized term defined herein shall relate only to the Class A(2014-2) Notes and no other Tranche of Notes issued by the Issuer;

 (7) “including” and words of similar import will be deemed to be followed by “without limitation”; and 

(8) for purposes of determining any amount or making any calculation hereunder, such amount or calculation, (x) if specified to be as of
the first day of any Due Period, shall (a)

 
include any Notes issued during such Due Period as if such Notes had been outstanding on the first day of such Due Period and (b) give effect to any payments, deposits or other allocations
made on the Distribution Date related to the prior Due Period, and (y) if specified to be as of the close of business on the last day of any Due Period shall give effect to any payments, deposits or other allocations made on the related
Distribution Date. 
 “Accumulation Amount” means $70,833,333.34; provided, however, if the
commencement of the Accumulation Period is delayed in accordance with Section 2.11 hereof, the Accumulation Amount shall be determined in accordance with the definition of “Accumulation Amount” in the Indenture Supplement. 

“Accumulation Commencement Date” means February 1, 2016, or such later date as the Calculation Agent on behalf of the
Issuer determines in accordance with Section 2.11 hereof. 
 “Accumulation Period” has the meaning set forth in the
Indenture Supplement. 
 “Accumulation Period Length” means 12 months; provided, however, if the
commencement of the Accumulation Period is delayed in accordance with Section 2.11 hereof, the Accumulation Period Length shall be determined in accordance with the definition of “Accumulation Period Length” in the Indenture
Supplement. 
 “Accumulation Reserve Funding Period” shall not apply if the Calculation Agent on behalf of the
Issuer notifies the Indenture Trustee that it expects the Accumulation Period Length to be adjusted to one (1) month, and otherwise shall mean a period commencing on the first Distribution Date on which a condition in the right column of the
following table was in effect on the immediately preceding Distribution Date, if the Distribution Date is a Distribution Date described in the corresponding left column of the following table, and ending on the Distribution Date immediately
preceding the earlier to occur of: 
 (x) the Expected Maturity Date for the Class A(2014-2) Notes and 

(y) the Principal Payment Date on which the Outstanding Dollar Principal Amount of the Class A(2014-2) Notes is paid in full. 

 

			
	 Distribution Date:
	  	 Condition:

		
	(a) The Distribution Date occurring three (3) calendar months prior to the first scheduled Distribution Date of the Accumulation Period (as adjusted in accordance with Section 2.11 hereof) and any following Distribution
Date	  	No condition.
		
	(b) The Distribution Date occurring four (4) calendar months prior to the first scheduled Distribution Date of the Accumulation Period (as adjusted in accordance with Section 2.11 hereof) and any following Distribution
Date	  	The three-month rolling average Excess Spread Percentage is less than 4%.

  
 2 

			
		
	(c) The Distribution Date occurring six (6) calendar months prior to the first scheduled Distribution Date of the Accumulation Period (as adjusted in accordance with Section 2.11 hereof) and any following Distribution Date	  	The three-month rolling average Excess Spread Percentage is less than 3%.
		
	(d) The Distribution Date occurring twelve (12) calendar months prior to the first scheduled Distribution Date of the Accumulation Period (as adjusted in accordance with Section 2.11 hereof) and any following Distribution
Date	  	The three-month rolling average Excess Spread Percentage is less than 2%.

 provided, however, if at any point the Accumulation Reserve Funding Period has not commenced because no condition
requiring funding has occurred or the Calculation Agent has determined that the Accumulation Period Length will be shortened to one (1) month, and subsequently a condition requiring funding occurs and the Calculation Agent determines that the
Accumulation Period Length will not be so shortened, the Accumulation Reserve Funding Period shall commence on the following Distribution Date. 

“Class A Tranche Interest Allocation” for Class A(2014-2) Notes for any Distribution Date means the sum of (a) the
Class A Interest for Class A(2014-2) and (b) the amount of any shortfall in the amount of funds on deposit in the Interest Funding Subaccount for the Class A(2014-2) Notes caused by the unavailability of the proceeds of any Permitted
Investments. 
 “Class A(2014-2) Adverse Event” means the occurrence of any of the following: (a) an Early
Redemption Event with respect to the Class A(2014-2) Notes or (b) an Event of Default and acceleration of the Class A(2014-2) Notes; provided, however, that if the only such event to have occurred is an Excess Spread Early
Redemption Event for which an Excess Spread Early Redemption Cure has occurred, a Class A(2014-2) Adverse Event shall not be treated as continuing from and after the date of such cure. 

“Class A(2014-2) Note” means any Note, in the form set forth in Exhibit A hereto, designated therein as a Class
A(2014-2) Note and duly executed and authenticated in accordance with the Indenture. 
 “Class A(2014-2) Noteholder”
means a Person in whose name a Class A(2014-2) Note is registered in the Note Register. 
 “Class A(2014-2) Termination
Date” means the earliest to occur of (a) the Principal Payment Date on which the Outstanding Dollar Principal Amount of the Class A(2014-2) Notes is paid in full, (b) the Legal Maturity Date and (c) the date on which the
Indenture is discharged and satisfied pursuant to Article VI thereof. 
 “Excess Spread Percentage” for any
Distribution Date means a fraction, the numerator of which is the Excess Spread Amount for such Distribution Date multiplied by 12 and the denominator of which is the sum of the Nominal Liquidation Amounts of all Tranches of DiscoverSeries
Notes as of the first day of the related Due Period. 
 “Expected Maturity Date” means February 15, 2017. 

  
 3 

 “Indenture” means the Indenture dated as of July 26, 2007 between
the Issuer and Indenture Trustee, as amended by the First Amendment to Indenture, dated as of June 4, 2010, as such agreement may be further amended, supplemented, restated, amended and restated, replaced or otherwise modified from time to
time. 
 “Indenture Supplement” means the Amended and Restated Indenture Supplement dated as of June 4,
2010, for the DiscoverSeries Notes, by and between the Issuer and the Indenture Trustee, as the same may be further amended, supplemented, restated, amended and restated, replaced or otherwise modified from time to time. 

“Initial Dollar Principal Amount” means $850,000,000, or such higher amount as is specified in any Notice of Additional
Issuance under Section 2.09 hereof. 
 “Interest Accrual Period” means, with respect to any Interest Payment Date, the
period from and including the previous Interest Payment Date (or, in the case of the first Interest Payment Date for any Class A(2014-2) Note, from and including the applicable Issuance Date) to but excluding such Interest Payment Date. 

“Interest Payment Date” means the fifteenth day of each February, May, August and November commencing in May 2014, or
if such fifteenth day is not a Business Day, the next succeeding Business Day. 
 “Issuance Date” means
March 11, 2014 with respect to all Class A(2014-2) Notes issued on the date hereof and, with respect to any additional Class A(2014-2) Notes issued pursuant to Section 2.09 hereof, any Issuance Date specified in the Notice of Additional
Issuance delivered thereunder. 
 “Legal Maturity Date” means August 15, 2019. 

“LIBOR” means, with respect to any LIBOR Determination Date, the rate for three-month deposits in United States
dollars which appears on Reuters Screen LIBOR01 as of 11:00 a.m., London time, on such day. If such rate does not appear on Reuters Screen LIBOR01, the rate will be determined by the Indenture Trustee on the basis of the rates at which three-month
deposits in United States dollars are offered by major banks in the London interbank market, selected by the Indenture Trustee, at approximately 11:00 a.m., London time, on such day to prime banks in the London interbank market. The Indenture
Trustee will request the principal London office of at least four banks to provide a quotation of its rate. If at least two such quotations are provided, the rate will be the arithmetic mean of the quotations. If fewer than two quotations are
provided as requested, the rate for that day will be the arithmetic mean of the rates quoted by four major banks in New York City, selected by the Trustee, at approximately 11:00 a.m., New York City time, on that day for three-month loans in United
States dollars to leading European banks. If LIBOR with respect to a LIBOR Determination Date is not determined pursuant to the foregoing, LIBOR with respect to such LIBOR Determination Date will be LIBOR with respect to the immediately prior LIBOR
Determination Date. 

  
 4 

 “LIBOR Business Day,” if applicable, shall mean a day other than a Saturday or a
Sunday on which banking institutions in both the City of London, England and in New York, New York are not required or authorized by law to be closed. 

“LIBOR Determination Date” means the second LIBOR Business Day immediately preceding the commencement of an Interest
Accrual Period. 
 “Note Interest Rate” means (i) with respect to the first Interest Accrual Period,
0.40082% per annum and (ii) with respect to each following Interest Accrual Period, LIBOR + 0.20% per annum, calculated on the basis of the actual number of days elapsed and a 360-day year. 

“Notice of Additional Issuance” has the meaning set forth in Section 2.09 hereof. 

“Required Daily Deposit Target Finance Charge Amount” means, for any day in a Due Period, an amount equal to the Class A
Tranche Interest Allocation for the related Distribution Date; provided, however, that for purposes of determining the Required Daily Deposit Target Finance Charge Amount on any day on which the Class A Tranche Interest Allocation cannot
be determined because the LIBOR Determination Date for the applicable Interest Accrual Period has not yet occurred, the Required Daily Deposit Target Finance Charge Amount shall be the Class A Tranche Interest Allocation determined based on a
pro forma calculation made on the assumption that LIBOR will be LIBOR for the applicable period determined on the first day of such calendar month, multiplied by 1.25. 

“Required Daily Deposit Target Principal Amount” means, for any day in a Due Period, (i) if such Due Period is in the
Accumulation Period for the Class A(2014-2) Notes, the Accumulation Amount, (ii) if such day is on or after the occurrence and during the continuance of a Class A(2014-2) Adverse Event, the Nominal Liquidation Amount of the Class A(2014-2)
Notes, and (iii) in all other circumstances, zero. 
 “Required Subordinated Amount of Class B Notes” means,
for the Class A(2014-2) Notes for any date of determination, an amount equal to the product of 
 (a) the Required Subordinated
Percentage of Class B Notes for such Class A(2014-2) Notes on such date of determination and 
 (b) the Nominal Liquidation Amount of such
Class A(2014-2) Notes on such date of determination; 
 provided, however, that for any date of determination on or after the occurrence and during
the continuation of a Class A(2014-2) Adverse Event, the Required Subordinated Amount of Class B Notes for the Class A(2014-2) Notes will be the greater of 

(x) the amount determined above for such date of determination and 

(y) the amount determined above for the date immediately prior to the date on which such Class A(2014-2) Adverse Event shall have occurred.

 “Required Subordinated Amount of Class C Notes” means, for the Class A(2014-2) Notes for any date of
determination, an amount equal to the product of 

  
 5 

 (a) the Required Subordinated Percentage of Class C Notes for such Class A(2014-2) Notes on such
date of determination and 
 (b) the Nominal Liquidation Amount of such Class A(2014-2) Notes on such date of determination; 

provided, however, that for any date of determination on or after the occurrence and during the continuation of a Class A(2014-2) Adverse Event,
the Required Subordinated Amount of Class C Notes for the Class A(2014-2) Notes will be the greater of 
 (x) the amount determined
above for such date of determination and 
 (y) the amount determined above for the date immediately prior to the date on which such Class
A(2014-2) Adverse Event shall have occurred. 
 “Required Subordinated Amount of Class D Notes” means, for the Class
A(2014-2) Notes for any date of determination, an amount equal to the product of 
 (a) the Required Subordinated Percentage of Class
D Notes for such Class A(2014-2) Notes on such date of determination and 
 (b) the Nominal Liquidation Amount of such Class A(2014-2) Notes
on such date of determination; 
 provided, however, that for any date of determination on or after the occurrence and during the continuation of a
Class A(2014-2) Adverse Event, the Required Subordinated Amount of Class D Notes for the Class A(2014-2) Notes will be the greater of 

(x) the amount determined above for such date of determination and 

(y) the amount determined above for the date immediately prior to the date on which the Class A(2014-2) Adverse Event shall have occurred. 

“Required Subordinated Percentage of Class B Notes” means, for the Class A(2014-2) Notes, 7.284768%, subject to
adjustment in accordance with Section 2.02. 
 “Required Subordinated Percentage of Class C Notes” means, for
the Class A(2014-2) Notes, 9.271523%, subject to adjustment in accordance with Section 2.02. 
 “Required Subordinated
Percentage of Class D Notes” means, for the Class A(2014-2) Notes, 15.894040%, subject to adjustment in accordance with Section 2.02. 

“Reuters Screen LIBOR01” means the display page currently so designated on the Reuters Screen (or such other page as
may replace that page on that service for the purpose of displaying comparable rates or prices). 
 “Specified
Rating” means, for the Class A(2014-2) Notes, Aaa(sf) with respect to Moody’s, AAA(sf) with respect to Standard & Poor’s and AAAsf with respect to Fitch. 

  
 6 

 “Stated Principal Amount” means $850,000,000 or such higher amount as is
specified in any Notice of Additional Issuance under Section 2.09. 
 “Targeted Accumulation Reserve Subaccount
Deposit” means, with respect to any Distribution Date during the Accumulation Reserve Funding Period, an amount equal to (i) 0.5% of the Outstanding Dollar Principal Amount of the Class A(2014-2) Notes as of the close of business on
the last day of the related Due Period or (ii) any other amount designated by the Calculation Agent on behalf of the Issuer. 

Section 1.02 Representations and Warranties of Issuer. The Issuer represents and warrants that: 

(a) the Issuer has been duly formed and is validly existing as a statutory trust in good standing under the laws of the State of Delaware, and
has full power and authority to execute and deliver this Terms Document and to perform the terms and provisions hereof; 
 (b) the execution,
delivery and performance of this Terms Document by the Issuer have been duly authorized by all necessary corporate and statutory trust proceedings of any Beneficiary and the Owner Trustee, do not require any approval or consent of any governmental
agency or authority, and do not and will not conflict with any material provision of the Certificate of Trust or the Trust Agreement of the Issuer; 

(c) this Terms Document is the valid, binding and enforceable obligation of the Issuer, except as the same may be limited by receivership,
insolvency, reorganization, moratorium or other laws relating to the enforcement of creditors’ rights generally or by general equity principles; 

(d) to the best of the Issuer’s knowledge, this Terms Document will not conflict with any law or governmental regulation or court decree
applicable to it; 
 (e) the Issuer is not required to be registered under the Investment Company Act; 

(f) all information heretofore furnished by the Issuer in writing to the Indenture Trustee for purposes of or in connection with this Terms
Document or any transaction contemplated hereby is, and all such information hereafter furnished by the Issuer in writing to the Indenture Trustee will be, true and accurate in every material respect or based on reasonable estimates on the date as
of which such information is stated or certified; and 
 (g) to the best knowledge of the Issuer, there are no proceedings or investigations
pending against the Issuer before any court, regulatory body, administrative agency, or other tribunal or governmental instrumentality having jurisdiction over the Issuer (i) asserting the invalidity of this Terms Document, (ii) seeking to
prevent the consummation of any of the transactions contemplated by this Terms Document or (iii) seeking any determination or ruling which in the Issuer’s judgment would materially and adversely affect the performance by the Issuer of its
obligations under this Terms Document or the validity or enforceability of this Terms Document. 

  
 7 

 Section 1.03 Representations and Warranties of Indenture Trustee. The Indenture
Trustee represents and warrants and any successor trustee shall represent and warrant that: 
 (a) The Indenture Trustee is organized,
existing and in good standing under the laws of the United States of America; 
 (b) The Indenture Trustee has full power, authority and
right to execute, deliver and perform this Terms Document, and has taken all necessary action to authorize the execution, delivery and performance by it of this Terms Document; and 

(c) This Terms Document has been duly executed and delivered by the Indenture Trustee. 

Section 1.04 Limitations on Liability. 

(a) It is expressly understood and agreed by the parties hereto that (i) this Terms Document is executed and delivered by the Owner
Trustee not individually or personally but solely as Owner Trustee under the Trust Agreement, in the exercise of the powers and authority conferred and vested in it, (ii) each of the representations, undertakings and agreements herein made on
the part of the Issuer is made and intended not as a personal representation, undertaking or agreement by the Owner Trustee but is made and intended for the purpose of binding only the Issuer, (iii) nothing herein contained will be construed as
creating any liability on the Owner Trustee individually or personally, to perform any covenant of the Issuer either expressed or implied herein, all such liability, if any, being expressly waived by the parties to this Terms Document and by any
Person claiming by, through or under them and (iv) under no circumstances will the Owner Trustee be personally liable for the payment of any indebtedness or expenses of the Issuer or be liable for the breach or failure of any obligation,
representation, warranty or covenant made or undertaken by the Issuer under this Terms Document or any related documents. 
 (b) None of the
Indenture Trustee, the Owner Trustee, the Calculation Agent, any Beneficiary, the Depositor, any Master Servicer or any Servicer or any of their respective officers, directors, employees, incorporators or agents will have any liability with respect
to this Terms Document, and recourse may be had solely to the Collateral pledged to secure these Class A(2014-2) Notes under the Indenture, the Indenture Supplement and this Terms Document. 

Section 1.05 Governing Law. THIS TERMS DOCUMENT WILL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW
YORK, INCLUDING SECTION 5-1401 OF THE GENERAL OBLIGATION LAW, WITHOUT REFERENCE TO ANY CONFLICT OF LAW PROVISIONS THAT WOULD RESULT IN THE APPLICATION OF THE LAWS OF ANY OTHER STATE. 

Section 1.06 Counterparts. This Terms Document may be executed in any number of counterparts, each of which when so executed will
be deemed to be an original, but all such counterparts will together constitute but one and the same instrument. 
 Section 1.07
Ratification of Indenture and Indenture Supplement. As supplemented by this Terms Document, each of the Indenture and the Indenture Supplement is in all respects 

  
 8 

 
ratified and confirmed and the Indenture as supplemented by the Indenture Supplement and this Terms Document shall be read, taken and construed as one and the same instrument. 

ARTICLE II 
 The Class A(2014-2)
Notes 
 Section 2.01 Creation and Designation. There is hereby created a Tranche of Class A Notes to be issued pursuant to
this Terms Document, the Indenture and the Indenture Supplement to be known as the “DiscoverSeries Class A(2014-2) Notes.” 

Section 2.02 Adjustments to Required Subordinated Percentages and Amount. 

(a) On any date, the Issuer may, at the direction of the Beneficiary, change the Required Subordinated Percentage of Class B Notes, the
Required Subordinated Percentage of Class C Notes or the Required Subordinated Percentage of Class D Notes, in each case for the Class A(2014-2) Notes, without the consent of any Noteholders; provided that the Issuer has received written
confirmation from each applicable Note Rating Agency that the change in such percentage will not result in a Ratings Effect for any Tranche of Outstanding DiscoverSeries Notes. 

(b) On any date, the Issuer may, at the direction of the Beneficiary, replace all or a portion of the Required Subordinated Amount of
Class B Notes, the Required Subordinated Amount of Class C Notes or the Required Subordinated Amount of Class D Notes, in each case for the Class A(2014-2) Notes with a different form of credit enhancement (including, without limitation, a cash
collateral account, a letter of credit, a reserve account, a surety bond, an insurance policy or a collateral interest, or any combination thereof) and may add such definitions and other terms and make such additional amendments to this Terms
Document as shall be necessary for such replacement without the consent of any Noteholders, provided that the Issuer has received written confirmation from each applicable Note Rating Agency that such replacement and such other amendments
will not result in a Ratings Effect for any Tranche of Outstanding DiscoverSeries Notes. 
 Section 2.03 Interest
Payment. For each Interest Payment Date, the amount of interest due with respect to the Class A(2014-2) Notes shall be an amount equal to 
  

	 	(i)	(A) a fraction, the numerator of which is the actual number of days in the related Interest Accrual Period and the denominator of which is 360, times 

(B) the Note Interest Rate in effect with respect to such related Interest Accrual Period, times 

 

	 	(ii)	the Outstanding Dollar Principal Amount of the Class A(2014-2) Notes determined as of the first date of such related Interest Accrual Period, plus 

  
 9 

 any Class A Tranche Interest Allocation Shortfall for such Class A(2014-2) Notes for the immediately
preceding Interest Payment Date, together with interest thereon at the Note Interest Rate in effect with respect to such related Interest Accrual Period, calculated on the basis of the actual number of days in the related Interest Accrual Period and
a 360-day year provided, however, that upon the acceleration of the Class A(2014-2) Notes following an Event of Default or upon the occurrence and during the continuance of an Early Redemption Event (other than an Excess Spread Early
Redemption Event for which an Excess Spread Early Redemption Cure has occurred), interest shall become due on each Distribution Date and the amount of interest with respect to the Class A(2014-2) Notes shall be an amount equal to 

 

	 	(i)	(A) a fraction, the numerator of which is the actual number of days in the related Monthly Interest Accrual Period and the denominator of which is 360, times 

(B) the Note Interest Rate in effect with respect to related Interest Accrual Period, times 

 

	 	(ii)	the Outstanding Dollar Principal Amount of the Class A(2014-2) Notes determined as of the first date of such related Monthly Interest Accrual Period, plus 

any Class A Tranche Interest Allocation Shortfall for such Class A(2014-2) Notes for the immediately preceding Distribution Date, together with interest
thereon at the Note Interest Rate in effect with respect to such related Interest Accrual Period, calculated on the basis of the actual number of days in the related Monthly Interest Accrual Period and a 360-day year. Upon the acceleration of the
Class A(2014-2) Notes following an Event of Default or upon the occurrence and during the continuance of an Early Redemption Event (other than an Excess Spread Early Redemption Event for which an Excess Spread Early Redemption Cure has occurred),
notwithstanding anything to the contrary in Section 3.04 of the Indenture Supplement, an amount equal to the interest due on each Distribution Date (including any amount due with respect to an Interest Allocation Shortfall) will be withdrawn
from the Interest Funding Subaccount for such Tranche and remitted to the applicable Paying Agent(s). 
 Section 2.04 Notification
of LIBOR. On each LIBOR Determination Date, the Indenture Trustee shall send to the Issuer, the Beneficiary, each applicable Master Servicer and any stock exchange on which the Class A(2014-2) Notes are then listed (if the rules of such exchange
so require), by facsimile transmission or electronic transmission, notification of LIBOR for the following Interest Accrual Period. 

Section 2.05 Payments of Interest and Principal. 

(a) The Issuer will cause interest to be paid on each Interest Payment Date and principal to be paid on the Expected Maturity Date;
provided, however, that it shall not be an Event of Default if principal is not paid in full on such Expected Maturity Date unless funds for such payment have been allocated in accordance with Section 3.01 of the Indenture
Supplement; and provided, further, that if a Class A(2014-2) Adverse Event has occurred and is continuing, principal will instead be payable in monthly installments on each Principal Payment Date for the Class A(2014-2) Notes in
accordance with Sections 3.01 and 3.05 of the Indenture Supplement. All payments of interest and principal on the Class A(2014-2) Notes shall be made as set forth in Section 1102 of the Indenture. 

(b) The right of the Class A(2014-2) Noteholders to receive payments from the Issuer will terminate on the Class A(2014-2) Termination Date.

 (c) All payments of principal, interest or other amounts to the Class A(2014-2) Noteholders will be made pro rata based on the
Stated Principal Amount of their Class A(2014-2) Notes. 
 Section 2.06 Form of Delivery of Class A(2014-2) Notes; Depository;
Denominations. 
 (a) The Class A(2014-2) Notes shall be delivered in the form of a Global Note which shall be a Registered Note as
provided in Section 204 of the Indenture. The form of the Class A(2014-2) Notes is attached hereto as Exhibit A. 
 (b) The Depository
for the Class A(2014-2) Notes shall be The Depository Trust Company, and the Class A(2014-2) Notes shall initially be registered in the name of Cede & Co., its nominee. 

(c) The Class A(2014-2) Notes will be issued in minimum denominations of $200,000 and integral multiples of $1,000 in excess of that amount.

 Section 2.07 Delivery and Payment for the Class A(2014-2) Notes. The Issuer shall execute and deliver the Class A(2014-2)
Notes to the Indenture Trustee for authentication, and the Indenture Trustee shall deliver the Class A(2014-2) Notes when authenticated, each in accordance with Sections 203 and 303 of the Indenture. 

  
 10 

 Section 2.08 Targeted Deposits to the Accumulation Reserve Account. The deposit
targeted to be made to the Accumulation Reserve Subaccount for the Class A(2014-2) Notes for any Due Period during the Accumulation Reserve Funding Period will be an amount equal to the Targeted Accumulation Reserve Subaccount Deposit minus any
amount on deposit in the Accumulation Reserve Subaccount for the Class A(2014-2) Notes. 
 Section 2.09 Additional Issuances of
Notes. Subject to clauses (ii), (iii), (iv) and (v) of Sections 2.02 and Section 2.03 of the Indenture Supplement, the Issuer may issue additional Class A(2014-2) Notes, so long as the following conditions precedent are satisfied:

 (a) the Issuer shall have given the Indenture Trustee written notice of such issuance of additional Class A(2014-2) Notes (the
“Notice of Additional Issuance”) at least one (1) Business Day in advance of the Issuance Date thereof, which notice shall include: 
  

	 	(i)	the Issuance Date of such additional Class A(2014-2) Notes; 

  

	 	(ii)	the amount of such additional Class A(2014-2) Notes being offered and the resulting Initial Dollar Principal Amount and Stated Principal Amount of Class A(2014-2) Notes; 

 

	 	(iii)	the date from which interest on such additional Class A(2014-2) Notes will accrue (which may be a date prior to the date of issuance thereof); 

 

	 	(iv)	the first Interest Payment Date on which interest will be paid on such additional Class A(2014-2) Notes; and 

  

	 	(v)	any other terms that the Issuer set forth in such notice of issuance of additional Class A(2014-2) Notes to clarify the rights of Holders of such additional Class A(2014-2) Notes or the effect of such issuance of
additional Class A(2014-2) Notes on any calculations to be made with respect to the Class A(2014-2) Notes, Class A, or the Issuer. 

 All
such terms shall be incorporated into and form a part of this Terms Document on and after the effective date of such Class A(2014-2) Notes; 

(b) no Class A(2014-2) Adverse Event has occurred and is continuing; and 

(c) either (i) the issuance of such additional Class A(2014-2) Notes would be treated as part of the same issue as the outstanding Class
A(2014-2) Notes under Treasury Regulation Sections 1.1275-1(f)(1) or 1.1275-2(k), or (ii) such additional Class A(2014-2) Notes are not issued with “original issue discount” for purposes of Section 1273 of the Code. 

The Issuer shall not have to satisfy the conditions set forth in Section 310 of the Indenture in connection with an issuance of
additional Class A(2014-2) Notes so long as such conditions were satisfied or waived in connection with the initial issuance of Class A(2014-2) Notes; 

  
 11 

 provided, however, that the Issuer shall have to deliver to the Indenture Trustee a Master Trust Tax
Opinion and an Issuer Tax Opinion with respect to such issuance. 
 Section 2.10 Investment of Funds in the Interest Funding
Subaccount. Notwithstanding Section 403(a) of the Indenture, funds held by the Indenture Trustee in the Interest Funding Subaccount for the Class A(2014-2) Notes will be invested in Permitted Investments that will mature in each case no
later than the following Distribution Date. 
 Section 2.11 Designation of Additional Amounts to be included in the Excess Spread
Amount for the DiscoverSeries Notes. At any time that any outstanding Series of certificates issued by the Master Trust provides that the Series Principal Collections allocated to such Series will be deposited into the Group Finance Charge
Collections Reallocation Account for the Master Trust to the extent necessary for application to cover shortfalls for other Series issued by the Master Trust, an amount equal to (x) all Series Principal Collections allocated to such Series,
multiplied by (y) a fraction, the numerator of which is the sum of the Nominal Liquidation Amounts for each outstanding Tranche of the DiscoverSeries Notes (including the Class A(2014-2) Notes and the denominator of which is (i) the
Aggregate Investor Interest for the Master Trust minus (ii) the sum of the Series Investor Interests for all such Series that provide that the Series Principal Collections allocated to such Series will be so deposited, is hereby
designated to be included in the Excess Spread Amount and shall be treated as Series Finance Charge Amounts for the DiscoverSeries. 

Section 2.12 Variable Accumulation Period. Notwithstanding anything to the contrary in Section 4.02 of the Indenture
Supplement, the Calculation Agent on behalf of the Issuer shall, by written notice to the Indenture Trustee, delay the commencement of the Accumulation Period for the Class A(2014-2) Notes and determine a new Accumulation Commencement Date, subject
to the conditions set forth in this Section 2.11; provided, however, that the Accumulation Period shall commence no later than the first day of the Due Period related to the Expected Maturity Date for the Class A(2014-2) Notes.
Any such delay by the Calculation Agent on behalf of the Issuer shall be made no later than the first day of the scheduled Due Period immediately preceding the first Due Period in the Accumulation Period (after giving effect to any prior delay in
the commencement of the Accumulation Period pursuant to this Section 2.11). 
 The Calculation Agent on behalf of the Issuer shall cause
such delay if the Calculation Agent determines in good faith that each of the following conditions will be satisfied: (i) the Calculation Agent on behalf of the Issuer delivers to the Indenture Trustee a certificate to the effect that the
Calculation Agent on behalf of the Issuer reasonably believes that, based on the payment rate and the anticipated availability of Series Principal Amounts and Reallocated Principal Amounts, the delay in the commencement of the Accumulation Period
for the Class A(2014-2) Notes will not result in any Tranche of Notes not being paid in full on the relevant Expected Maturity Date; (ii) such delay is permitted under the Series 2007-CC Series Supplement or any other applicable agreement
relating to any Additional Collateral Certificate; and (iii) the Accumulation Amount, the Accumulation Commencement Date and the Accumulation Period Length shall have been adjusted. The Calculation Agent on behalf of the Issuer shall not be
required to obtain confirmation from the applicable Note Rating Agencies that such delay in the commencement of the Accumulation Period will not result in a Ratings Effect for any Tranche of Outstanding DiscoverSeries Notes, unless at the time of
such delay there is a Tranche of Outstanding DiscoverSeries Notes, which were issued prior to January 1, 2009 and for which the commencement of the Accumulation Period for such Tranche of Notes has already been delayed pursuant to
Section 4.02 of the Indenture Supplement. If such confirmation from the applicable Note Rating Agency is not required, the Calculation Agent on behalf of the Issuer shall provide written notice to each applicable Note Rating Agency in the event
that the 

  
 12 

 
commencement of the Accumulation Period for the Class A(2014-2) Notes is delayed pursuant to this Section 2.11. 

Section 2.13 Permitted Investments. Notwithstanding anything to the contrary in the Indenture or the Pooling and Servicing
Agreement, with respect to the Class A(2014-2) Notes, for purposes of the definition of Permitted Investment, “Highest Rating” shall mean, with respect to Standard & Poor’s: 

(a) A-1 or AAA for funds on deposit in all Issuer Accounts other than Principal Funding Accounts; 

(b) A-1+ or AAA for funds on deposit in Principal Funding Accounts; or 

(c) any rating category which will not cause a reduction in or withdrawal of the rating of the Class A(2014-2) Notes, as confirmed in writing
by Standard & Poor’s. 
 [Remainder of page intentionally blank; signature page follows] 

  
 13 

 IN WITNESS WHEREOF, the parties hereto have caused this Terms Document to be duly executed, all
as of the day and year first above written. 
  

					
	DISCOVER CARD EXECUTION NOTE TRUST,
	    as Issuer
		
	By:	 	Wilmington Trust Company,
		 	  not in its individual capacity but solely as Owner

 Trustee

		
	By:	 	  

		 	Name: Jennifer A. Luce
		 	Title: Vice President
	
	U.S. BANK NATIONAL ASSOCIATION,
	    as Indenture Trustee
		
	By:	 	  

		 	Name: Edwin J. Janis
		 	Title: Vice President

 [Signature Page to Class A(2014-2) Terms Document] 

 DISCOVERSERIES CLASS A(2014-2) NOTE 

UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO
THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR TO SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO
CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF,
CEDE & CO., HAS AN INTEREST HEREIN. 
 THE HOLDER OF THIS NOTE, BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT AT ANY TIME
INSTITUTE AGAINST THE ISSUER, ANY MASTER TRUST OR ANY SPECIAL PURPOSE ENTITY THAT ACTS AS A DEPOSITOR WITH RESPECT TO ANY MASTER TRUST OR THE ISSUER, OR JOIN IN ANY INSTITUTION AGAINST THE ISSUER, ANY MASTER TRUST OR ANY SPECIAL PURPOSE ENTITY THAT
ACTS AS A DEPOSITOR WITH RESPECT TO ANY MASTER TRUST OR THE ISSUER, ANY RECEIVERSHIP, INSOLVENCY, BANKRUPTCY OR SIMILAR PROCEEDINGS, OR OTHER PROCEEDINGS UNDER ANY UNITED STATES FEDERAL OR STATE BANKRUPTCY OR SIMILAR LAW IN CONNECTION WITH ANY
OBLIGATIONS RELATING TO THE NOTES, THE INDENTURE, ANY DERIVATIVE AGREEMENT, ANY SUPPLEMENTAL CREDIT ENHANCEMENT AGREEMENT AND ANY SUPPLEMENTAL LIQUIDITY AGREEMENT. 

THE HOLDER OF THIS NOTE, BY ACCEPTANCE OF THIS NOTE, AND EACH HOLDER OF A BENEFICIAL INTEREST IN THIS NOTE, BY THE ACQUISITION OF A BENEFICIAL
INTEREST THEREIN, AGREE TO TREAT THE NOTES AS INDEBTEDNESS FOR APPLICABLE FEDERAL, STATE, AND LOCAL INCOME AND FRANCHISE TAX LAW AND FOR PURPOSES OF ANY OTHER TAX IMPOSED ON OR MEASURED BY INCOME. 

			
	REGISTERED	  	$[•] *
	No. 1	  	CUSIP NO. 254683BH7

 DISCOVER CARD EXECUTION NOTE TRUST 

Floating Rate 
 DISCOVERSERIES
CLASS A(2014-2) NOTE 
 DISCOVER CARD EXECUTION NOTE TRUST, a statutory trust created under the laws of the State of Delaware (herein
referred to as the “Issuer” or the “Note Issuance Trust”), for value received, hereby promises to pay to CEDE & CO., or registered assigns, subject to the following provisions, a principal sum of $[•]
([•] dollars) payable on the February 15, 2017 Payment Date (the “Expected Maturity Date”), except as otherwise provided below or in the Indenture or the Indenture Supplement (as defined on the reverse hereof);
provided, however, that the entire unpaid principal amount of this Note shall be due and payable on the August 15, 2019 Payment Date (the “Legal Maturity Date”). Interest will accrue on this Note at the rate of
three-month LIBOR + 0.20% per annum, provided that the interest rate applicable to the first Interest Accrual Period will be 0.40082% per annum, as more specifically set forth in the Class A(2014-2) Terms Document dated as of
March 11, 2014 (the “Terms Document”), between the Issuer and U.S. Bank National Association, as Indenture Trustee (the “Indenture Trustee”, which term includes any successor Indenture Trustee under the
Indenture), and shall be due and payable on each Interest Payment Date from and including the previous Interest Payment Date (or, in the case of the first Interest Payment Date for any Class A(2014-2) Notes, from and including the applicable
Issuance Date) to but excluding such Interest Payment Date. Interest will be computed on the basis of the actual number of days elapsed and a 360-day year. Such principal of and interest on this Note shall be paid in the manner specified on the
reverse hereof. 
 Notwithstanding the foregoing, the principal and interest may be payable monthly, and may be payable earlier or later
than the Expected Maturity Date, following an Event of Default or while an Early Redemption Event has occurred and is continuing. No principal or interest will be distributed on the Note following the distribution of proceeds of a Receivables Sale.

 The principal of and interest on this Note are payable in such coin or currency of the United States of America as at the time of payment
is legal tender for payment of public and private debts. 
 The Initial Dollar Principal Amount of the Class A(2014-2) Notes is
$850,000,000. 
 Reference is made to the further provisions of this Note set forth on the reverse hereof, which shall have the same effect
as though fully set forth on the face of this Note. 
 Unless the certificate of authentication hereon has been executed by the Indenture
Trustee whose name appears below by manual signature, this Note shall not be entitled to any benefit under the Indenture, Indenture Supplement or the Terms Document referred to on the reverse hereof, or be valid or obligatory for any purpose. 

 

	*	Denominations of $200,000 and in integral multiples of $1,000 in excess thereof. 

  
 2 

 IN WITNESS WHEREOF, the Issuer has caused this instrument to be signed, manually or in facsimile,
by its Authorized Officer. 
  

			
	 DISCOVER CARD EXECUTION NOTE TRUST, as Issuer

		
	By:	 	WILMINGTON TRUST COMPANY, not in its individual capacity, but solely as Owner Trustee
		
	By:	 	  

		 	Name:
		 	Title:
		
		 	Date:

  
 3 

 INDENTURE TRUSTEE’S CERTIFICATE OF AUTHENTICATION 

This is one of the Notes designated above and referred to in the within-mentioned Indenture. 

 

			
	 US BANK NATIONAL ASSOCIATION,

	     not in its individual capacity but solely as

    Indenture Trustee

		
	By:	 	  

		 	Name:
		 	Title:
		
		 	Date:

  
 4 

 REVERSE OF NOTE 

This Note is one of the Notes of a duly authorized issue of Notes of the Issuer, designated as its Class A(2014-2) DiscoverSeries Notes
(herein called the “Class A(2014-2) Notes”), all issued under an Indenture dated as of July 26, 2007, as amended by the First Amendment to Indenture, dated as of June 4, 2010 (such Indenture, as may be further amended,
restated, amended and restated, supplemented, replaced or otherwise modified from time to time, is herein called the “Indenture”), as supplemented by an Amended and Restated Indenture Supplement for the DiscoverSeries Notes, dated
as of June 4, 2010 (such Indenture Supplement, as may be further amended, restated, amended and restated, supplemented, replaced or otherwise modified from time to time, is herein called the “Indenture Supplement”), between the
Issuer and Indenture Trustee, to which Indenture and Indenture Supplement reference is hereby made for a statement of the respective rights and obligations thereunder of the Issuer, the Indenture Trustee and the Holders of the Notes. The Class
A(2014-2) Notes are subject to all terms of the Indenture, the Indenture Supplement and the Terms Document. All terms used in this Class A(2014-2) Note that are defined in the Indenture, the Indenture Supplement and the Terms Document shall have the
meanings assigned to them in or pursuant to the Indenture, the Indenture Supplement and the Terms Document. 
 The Class B Notes, the Class
C Notes and the Class D Notes of the DiscoverSeries and other tranches of Class A Notes of the DiscoverSeries will also be issued under the Indenture and the Indenture Supplement. 

The Class A(2014-2) Notes are and will be equally and ratably secured by the collateral pledged as security therefor as provided in the
Indenture and the Indenture Supplement. 
 Principal of the Class A(2014-2) Notes will be payable on the Expected Maturity Date in an amount
described on the face hereof except as otherwise provided in the Indenture or the Indenture Supplement. 
 As described above, the entire
unpaid principal amount of this Class A(2014-2) Note shall be due and payable on the Legal Maturity Date. Notwithstanding the foregoing, the entire unpaid principal amount of the Class A(2014-2) Notes shall be due and payable on the date on which an
Event of Default relating to the Class A(2014-2) Notes shall have occurred and be continuing and, except in the event of an insolvency related default, the Indenture Trustee or the Majority Holders of the applicable Series, Class or Tranche of
Outstanding Dollar Principal Amount of the Outstanding Notes have declared the Class A(2014-2) Notes to be immediately due and payable in the manner provided in Section 702 of the Indenture; provided, however, that such
acceleration of the entire unpaid principal amount of the Notes may be rescinded by the Majority Holders of such applicable Series, Class or Tranche of Notes. 

On any day occurring on or after the date on which the aggregate Nominal Liquidation Amount of any Tranche of Notes is reduced to less than 5%
of its highest Outstanding Dollar Principal Amount, the Depositor or any Affiliate thereof has the right, but not the obligation, to redeem such Tranche of Notes in whole but not in part, pursuant to Section 1202 of the Indenture. The
redemption price will be an amount equal to the Outstanding Dollar Principal Amount of such Tranche, plus accrued, unpaid and additional interest or principal accreted and unpaid on such Tranche to but excluding the date of redemption. 

  
 5 

 Subject to the terms and conditions of the Indenture, the Beneficiary, on behalf of the Note
Issuance Trust, may from time to time issue, or direct the Owner Trustee, on behalf of the Note Issuance Trust, to issue, one or more Series, Classes or Tranches of Notes. 

On each Payment Date, the Paying Agent shall distribute to each Holder of Class A(2014-2) Notes of record on the related Record Date (except
for the final distribution with respect to this Class A(2014-2) Note) such Holder’s pro rata share of the amounts held by the Paying Agent that are allocated and available on such Payment Date to pay interest and principal on the Class A
Notes. 
 Payments of interest on this Class A(2014-2) Note due and payable on each Payment Date, together with any installment of
principal, if any, to the extent not in full payment of this Class A(2014-2) Note, shall be made by check mailed to the Person whose name appears as the Registered Holder of this Class A(2014-2) Note on the Note Register as of the close of business
on each Record Date, except that with respect to Class A(2014-2) Notes registered on the Record Date in the name of the nominee of the clearing agency (initially, such nominee to be CEDE & CO.), payments will be made by wire transfer in
immediately available funds to the account designated by such nominee. Such checks shall be mailed to the Person entitled thereto at the address of such Person as it appears on the Note Register as of the applicable Record Date without requiring
that this Class A(2014-2) Note be submitted for notation of payment. Any reduction in the principal amount of this Class A(2014-2) Note (or any one or more Predecessor Notes) effected by any payments made on any Payment Date shall be binding upon
all future Holders of this Class A(2014-2) Note and of any Class A(2014-2) Note issued upon the registration of transfer hereof or in exchange hereof or in lieu hereof, whether or not noted hereon. If funds are expected to be available, as provided
in the Indenture, for payment in full of the then remaining unpaid principal amount of this Class A(2014-2) Note on a Payment Date, then the Indenture Trustee, in the name of and on behalf of the Issuer, will notify the Person who was the Registered
Holder hereof as of the Record Date preceding such Payment Date by notice mailed within five days of such Payment Date and the amount then due and payable shall be payable only upon presentation and surrender of this Class A(2014-2) Note at the
Indenture Trustee’s principal Corporate Trust Office or at the office of the Indenture Trustee’s agent appointed for such purposes located in the City of New York. On any payment of interest or principal being made, details of such payment
shall be entered by the Indenture Trustee on behalf of the Issuer in Schedule A hereto. 
 As provided in the Indenture and subject to
certain limitations set forth therein and as set forth in the first legend on the face hereof, the transfer of this Class A(2014-2) Note may be registered on the Note Register upon surrender of this Class A(2014-2) Note for registration of transfer
at the office or agency designated by the Issuer pursuant to the Indenture, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Indenture Trustee duly executed by, the Holder hereof or his attorney duly
authorized in writing, with such signature guaranteed by a commercial bank or trust company located, or having a correspondent located, in the City of New York or the city in which the Corporate Trust Office is located, or a member firm of a
national securities exchange, and such other documents as the Indenture Trustee may require, and thereupon one or more new Class A(2014-2) Notes of authorized denominations and in the same aggregate principal amount will be issued to the designated
transferee or transferees. No service charge will be charged for any registration of transfer or exchange of this Class A(2014-2) Note, but the transferor may be required to pay a sum 

  
 6 

 
sufficient to cover any tax or other governmental charge that may be imposed in connection with any such registration of transfer or exchange. 

To the fullest extent permitted by applicable law, each Noteholder or Note Owner, by acceptance of a Class A(2014-2) Note or, in the case of a
Note Owner, a beneficial interest in a Class A(2014-2) Note, covenants and agrees that by accepting the benefits of the Indenture it will not at any time institute against the Issuer, any Master Trust or any special purpose entity that acts as a
depositor with respect to any Master Trust or the Issuer, or join in any institution against the Issuer, any Master Trust or any special purpose entity that acts as a depositor with respect to any Master Trust or the Issuer of, any receivership,
insolvency, bankruptcy or other similar proceedings, or other proceedings under any United States federal or state bankruptcy or similar law in connection with any obligations relating to the Notes, the Indenture, any Derivative Agreement, any
Supplemental Credit Enhancement Agreement and any Supplemental Liquidity Agreement. 
 Prior to the due presentment for registration of
transfer of this Class A(2014-2) Note, the Issuer, the Indenture Trustee and any agent of the Issuer or the Indenture Trustee may treat the Person in whose name this Class A(2014-2) Note (as of the day of determination or as of such other date as
may be specified in the Indenture) is registered as the owner hereof for all purposes, whether or not this Class A(2014-2) Note be overdue, and neither the Issuer, the Indenture Trustee nor any such agent shall be affected by notice to the contrary.

 The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and
obligations of the Issuer and the rights of the Holders of the Notes under the Indenture at any time by the Issuer with the consent of the Holders of Notes representing not less than 66 2/3% of the Outstanding Dollar Principal Amount of each
adversely affected Series, Class or Tranche of Notes. The Indenture also contains provisions permitting the Holders of Notes representing specified percentages of the Outstanding Dollar Principal Amount of the Notes, on behalf of the Holders of all
the Notes, to waive compliance by the Issuer with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Class A(2014-2) Note shall be conclusive and
binding upon such Holder and upon all future Holders of this Class A(2014-2) Note and of any Note issued upon the registration of transfer hereof or in exchange hereof or in lieu hereof whether or not notation of such consent or waiver is made upon
this Class A(2014-2) Note. The Indenture also permits the Indenture Trustee to amend or waive certain terms and conditions set forth in the Indenture without the consent of Holders of the Notes issued thereunder. 

The term “Issuer” as used in this Class A(2014-2) Note includes any successor to the Issuer under the Indenture. 

The Issuer is permitted by the Indenture, under certain circumstances, to merge or consolidate, subject to the rights of the Indenture Trustee
and the Holders of Notes under the Indenture. 
 The Class A(2014-2) Notes are issuable only in registered form in denominations as provided
in the Indenture, subject to certain limitations therein set forth. 

  
 7 

 THIS CLASS A(2014-2) NOTE AND THE INDENTURE WILL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY
THE LAWS OF THE STATE OF NEW YORK, INCLUDING SECTION 5-1401 OF THE GENERAL OBLIGATION LAW, WITHOUT REFERENCE TO ANY CONFLICT OF LAW PROVISIONS THAT WOULD RESULT IN THE APPLICATION OF THE LAWS OF ANY OTHER STATE. 

No reference herein to the Indenture and no provision of this Class A(2014-2) Note or of the Indenture shall alter or impair the obligation of
the Issuer, which is absolute and unconditional, to pay the principal of and interest on this Class A(2014-2) Note at the times, place, and rate, and in the coin or currency herein prescribed. 

No recourse may be taken, directly or indirectly, with respect to the obligations of the Issuer on the Notes or under the Indenture or any
certificate or other writing delivered in connection therewith, against (i) the Owner Trustee in its individual capacity, (ii) any owner of a beneficial interest in the Issuer or (iii) any partner, owner, beneficiary, agent, officer,
director or employee of the Owner Trustee in its individual capacity, any holder of a beneficial interest in the Issuer or any successor or assign of the Owner Trustee in its individual capacity, except as any such Person may have expressly agreed
(it being understood that the Owner Trustee has no such obligations in its individual capacity). The Holder of this Class A(2014-2) Note by the acceptance hereof agrees that, except as expressly provided in the Indenture and the Indenture Supplement
in the case of an Event of Default under the Indenture, the Holder shall have no claim against any of the foregoing for any deficiency, loss or claim therefrom; provided, however, that nothing contained herein shall be taken to prevent
recourse to, and enforcement against, the assets of the Issuer for any and all liabilities, obligations and undertakings contained in the Indenture or in this Class A(2014-2) Note. 

  
 8 

 ASSIGNMENT 

Social Security or taxpayer I.D. or other identifying number of assignee 
  

 
 FOR VALUE RECEIVED, the undersigned hereby
sells, assigns and transfers unto 
 (name and address of assignee) 

the within Note and all rights thereunder, and hereby irrevocably constitutes and appoints attorney, to transfer said Note on the books kept for registration
thereof, with full power of substitution in the premises. 
  

							
	Dated:	 	  
	  	  
	 	  *
		 		  	Signature Guaranteed:

  
  

	*	NOTE: The signature to this assignment must correspond with the name of the registered owner as it appears on the face of the within Note in every particular, without alteration, enlargement or any change whatsoever.

  
 9 

 SCHEDULE A 

PART I 
 INTEREST PAYMENTS

  

									
	 Interest

Payment Date
	  	 Date of
Payment
	  	 Total Amount
of Interest

Payable
	  	 Amount of
Interest Paid
	  	 Confirmation of
payment by or
on
behalf of the Note
 Issuance

Trust

	1.	  		  		  		  	
	2.	  		  		  		  	
	3.	  		  		  		  	
	4.	  		  		  		  	
	5.	  		  		  		  	
	6.	  		  		  		  	
	7.	  		  		  		  	
	8.	  		  		  		  	
	9.	  		  		  		  	
	10.	  		  		  		  	
	11.	  		  		  		  	
	12.	  		  		  		  	

  
 10 

 PART II 

PRINCIPAL PAYMENTS 
  

									
	 Principal

Payment Date
	  	 Date of Payment
	  	 Total Amount
of Principal

Payable
	  	 Total Amount

Paid
	  	 Confirmation of
payment by or
on
behalf of the Note
 Issuance

Trust

	1.	  		  		  		  	
	2.	  		  		  		  	
	3.	  		  		  		  	
	4.	  		  		  		  	
	5.	  		  		  		  	
	6.	  		  		  		  	
	7.	  		  		  		  	
	8.	  		  		  		  	
	9.	  		  		  		  	
	10.	  		  		  		  	
	11.	  		  		  		  	
	12.	  		  		  		  	

  
 11EX-4.2

 Exhibit 4.2 

Execution Version 
 FOURTH
AMENDED AND RESTATED STOCKHOLDERS’ 
 AGREEMENT 

dated as of 
 NOVEMBER 1,
2013 
 among 
 TV2
HOLDING COMPANY 
 and 

CERTAIN STOCKHOLDERS OF THE COMPANY AND OTHER 

PERSONS NAMED HEREIN 

 TABLE OF CONTENTS 

 

							
	 	 	 	  	PAGE	 
		
	 ARTICLE 1 DEFINITIONS
	  	 	2	  
			
	 Section 1.01
	 	 Definitions
	  	 	2	  
	 Section 1.02
	 	 Other Definitional and Interpretative Provisions
	  	 	11	  
		
	 ARTICLE 2 CORPORATE GOVERNANCE
	  	 	12	  
			
	 Section 2.01
	 	 Composition of the Board of Directors
	  	 	12	  
	 Section 2.02
	 	 Removal
	  	 	12	  
	 Section 2.03
	 	 Vacancies
	  	 	13	  
	 Section 2.04
	 	 Committees
	  	 	13	  
	 Section 2.05
	 	 Director Expenses; Directors’ and Officers’ Insurance; Indemnity and Exculpation
	  	 	13	  
	 Section 2.06
	 	 Agreement to Implement the Foregoing
	  	 	13	  
	 Section 2.07
	 	 No Liability for Election of Recommended Director
	  	 	14	  
	 Section 2.08
	 	 Irrevocable Proxy
	  	 	14	  
	 Section 2.09
	 	 Termination/Amendment
	  	 	14	  
		
	 ARTICLE 3 RIGHTS AND OBLIGATIONS WITH RESPECT TO TRANSFER; PREEMPTIVE RIGHTS
	  	 	14	  
			
	 Section 3.01
	 	 General Restrictions
	  	 	14	  
	 Section 3.02
	 	 Agreement to be Bound
	  	 	15	  
	 Section 3.03
	 	 Legends
	  	 	15	  
	 Section 3.04
	 	 Preemptive Rights
	  	 	16	  
	 Section 3.05
	 	 Rights of First Offer
	  	 	17	  
	 Section 3.06
	 	 Prospective BSC Sale
	  	 	19	  
	 Section 3.07
	 	 Tag-Along Rights
	  	 	21	  
	 Section 3.08
	 	 Rights to Drag-Along
	  	 	22	  
		
	 ARTICLE 4 REGISTRATION RIGHTS
	  	 	24	  
			
	 Section 4.01
	 	 Demand Registration
	  	 	24	  
	 Section 4.02
	 	 Piggyback Registration
	  	 	26	  
	 Section 4.03
	 	 Lock-Up Agreements
	  	 	27	  
	 Section 4.04
	 	 Registration Procedures
	  	 	28	  
	 Section 4.05
	 	 Indemnification by the Company
	  	 	31	  
	 Section 4.06
	 	 Indemnification by Participating Stockholders
	  	 	31	  
	 Section 4.07
	 	 Conduct of Indemnification Proceedings
	  	 	31	  
	 Section 4.08
	 	 Contribution
	  	 	32	  
	 Section 4.09
	 	 Participation in Public Offering
	  	 	33	  
	 Section 4.10
	 	 Other Indemnification
	  	 	34	  

  
 - i - 

 TABLE OF CONTENTS 

(continued) 
  

							
	 	 	 	  	PAGE	 
			
	 Section 4.11
	 	 Cooperation by the Company
	  	 	34	  
	 Section 4.12
	 	 No Transfer of Registration Rights
	  	 	34	  
	 Section 4.13
	 	 Termination of Registration Rights
	  	 	34	  
		
	 ARTICLE 5 CERTAIN COVENANTS
	  	 	34	  
			
	 Section 5.01
	 	 Confidentiality
	  	 	34	  
	 Section 5.02
	 	 Financial Statements and Other Information
	  	 	36	  
	 Section 5.03
	 	 Inspection of Property
	  	 	37	  
	 Section 5.04
	 	 Limitations on Subsequent Registration Rights
	  	 	38	  
	 Section 5.05
	 	 Conflicting Agreements
	  	 	38	  
	 Section 5.06
	 	 Proprietary Information and Inventions Agreement
	  	 	38	  
	 Section 5.07
	 	 Director and Officer Insurance
	  	 	38	  
	 Section 5.08
	 	 Reservation of Common Stock
	  	 	38	  
	 Section 5.09
	 	 Stock Vesting
	  	 	38	  
	 Section 5.10
	 	 Termination
	  	 	39	  
		
	 ARTICLE 6 MISCELLANEOUS
	  	 	39	  
			
	 Section 6.01
	 	 Binding Effect; Assignability; Benefit
	  	 	39	  
	 Section 6.02
	 	 Notices
	  	 	39	  
	 Section 6.03
	 	 Waiver; Amendment; Termination
	  	 	40	  
	 Section 6.04
	 	 Fees and Expenses
	  	 	41	  
	 Section 6.05
	 	 Governing Law
	  	 	41	  
	 Section 6.06
	 	 Jurisdiction
	  	 	41	  
	 Section 6.07
	 	 WAIVER OF JURY TRIAL
	  	 	41	  
	 Section 6.08
	 	 Specific Enforcement
	  	 	41	  
	 Section 6.09
	 	 Counterparts; Effectiveness
	  	 	41	  
	 Section 6.10
	 	 Entire Agreement
	  	 	42	  
	 Section 6.11
	 	 Aggregation Of Stock
	  	 	42	  
	 Section 6.12
	 	 Severability
	  	 	42	  
	 Section 6.13
	 	 Not a Voting Trust
	  	 	42	  

  

			
	Exhibit A	  	Preferred Stockholders (including the Funds)
	Exhibit B	  	Common Legacy Stockholders
	Exhibit C	  	Additional Stockholders
	Exhibit D	  	Joinder Agreement

  
 - ii - 

 FOURTH AMENDED AND RESTATED STOCKHOLDERS’ AGREEMENT 

THIS FOURTH AMENDED AND RESTATED STOCKHOLDERS’ AGREEMENT (this “Agreement”) dated as of November 1, 2013 by and
among (i) TV2 Holding Company, a Delaware corporation (the “Company”), (ii) MPM BioVentures IV-QP, L.P., MPM BioVentures IV GmbH & Co. Beteiligungs KG and MPM Asset Management Investors BV4 LLC (collectively,
“MPM”), New Enterprise Associates 12, Limited Partnership, NEA Ventures 2008, Limited Partnership, (collectively, “NEA”), Delphi Ventures VII, L.P., Delphi BioInvestments VII, L.P., Delphi Ventures VIII, L.P. and
Delphi BioInvestments VIII, L.P. (collectively, “Delphi”), Thomas Weisel Healthcare Venture Partners, LP, Kearny Venture Partners, LP and Kearny Venture Partners Entrepreneurs Fund, L.P. (collectively, “TWK”),
Pinnacle Ventures Equity Fund II, L.P., Pinnacle Ventures Equity Fund II-O, L.P., Pinnacle Ventures II-A, L.P., Pinnacle Ventures II-B, L.P., Pinnacle Ventures II-C, L.P., Pinnacle Ventures II-R, L.P., Pinnacle Ventures Debt Fund III-A, L.P.,
Pinnacle Ventures Debt Fund III, L.P. and/or other Pinnacle affiliates (collectively, “Pinnacle”), Kaiser Permanente Ventures LLC- Series A, Kaiser Permanente Ventures LLC – Series B and The Permanente Federation LLC –
Series J (collectively, “KPV”) and Redmile Capital Fund, LP, Redmile Capital Offshore Fund, Ltd., Redmile Capital Offshore Fund II, Ltd., Redmile Special Opportunities Fund, Ltd. and Redmile Private Investments I, L.P.
(collectively, “Redmile”), Deerfield Special Situations Fund, L.P., Deerfield Special Situations International Master Fund, L.P., Deerfield Private Design Fund II, L.P. and Deerfield Private Design International II, L.P.
(collectively, “Deerfield”), Rock Springs Capital Master Fund LP (“Rock Springs”) and Permal Select Opportunities Ltd. and Permal Select Opportunities II Ltd. (collectively, “Permal” and together
with MPM, NEA, Delphi, TWK, Pinnacle, KPV, Redmile, Deerfield and Rock Springs the “Funds” and individually, each a “Fund”) as listed on Exhibit A, (iii) Boston Scientific Scimed, Inc., a Minnesota
corporation (“BSC”), (iv) Michael Chobotov, Joseph Humphrey and Robert Whirley (collectively, the “Founders”), (v) certain Persons other than the Funds listed as holders of Series A Preferred Stock, Series
B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and/or Series E Preferred Stock on Exhibit A (together with the Funds, the “Preferred Stockholders”), (vi) certain other Persons listed as
“Common Legacy Stockholders” on Exhibit B (collectively, the “Common Legacy Stockholders,” and together with the Persons other than Funds holding Series A Preferred Stock, the “Legacy
Stockholders”) and (vii) certain other stockholders of the Company who have joined as parties to this Agreement as listed on Exhibit C (the “Additional Stockholders”). “MPM,” “NEA,”
“Delphi,” “TWK,” “Pinnacle,” “KPV,” “Redmile,” “Deerfield,” “Rock Springs,” “Permal,” “Fund,” “BSC,” “Founders,” “Preferred
Stockholders,” “Common Legacy Stockholders,” “Legacy Stockholders,” and the “Additional Stockholders” shall each mean, if any such Person(s) shall have Transferred any of its “Company Securities” to any
of its “Permitted Transferees” (as such terms are defined below), such Person(s) and such Permitted Transferees, taken together, and any right, obligation or action that may be exercised or taken at the election of such entities or persons
may be taken at the election of such Person(s) and such Permitted Transferees. 

 W I T N E S S E T H : 

WHEREAS, certain of the Preferred Stockholders, BSC, the Founders, the Legacy Stockholders and the Additional Stockholders are parties to and
possess certain rights pursuant to the Third Amended and Restated Stockholders’ Agreement dated as of June 1, 2012 (the “Prior Stockholders’ Agreement”); 

WHEREAS, certain of the parties hereto are parties to the Series E Preferred Stock Purchase Agreement of even date herewith,
among the Company and the “Investors” listed on the Schedule of Investors thereto (the “Series E Purchase Agreement”), and it is a condition to the closing of the sale of the Series E Preferred Stock under the
Series E Purchase Agreement that such Investors and the Company, along with sufficient parties to amend the Prior Stockholders’ Agreement, shall have executed and delivered this Agreement; and 

WHEREAS, the parties hereto desire that this Agreement amend, restate, supersede and replace the Prior Stockholders’
Agreement in its entirety. 
 NOW, THEREFORE, in consideration of the mutual promises and covenants set forth herein and in the
Series E Purchase Agreement, the Company and the parties hereto hereby agree that the Prior Stockholders’ Agreement will be superseded and replaced in its entirety by this Agreement and the parties hereto further agree as follows: 

ARTICLE 1 

DEFINITIONS 

Section 1.01 Definitions. (a) The following terms, as used herein, have the following meanings: 

“Affiliate” means, with respect to any Person, any other Person directly or indirectly controlling, controlled by or under
common control with such Person, provided that, for purposes of this Agreement, (i) the Company shall not be deemed an Affiliate of any Stockholder and (ii) no Stockholder of the Company shall be deemed an Affiliate of the Company
or any other Stockholder or such other Stockholder’s Affiliates solely by reason of its ownership interest in the Company. For the purpose of this definition, the term “control” (including, with correlative meanings, the terms
“controlling,” “controlled by” and “under common control with”), as used with respect to any Person, shall mean the possession, directly or indirectly, of the power to direct or cause the direction
of the management and policies of such Person, whether through the ownership of voting securities, by contract (including any discretionary investment management agreement giving a Person discretionary authority to divest any securities in the
Company held by another Person) or otherwise. Notwithstanding anything to the contrary herein, Kaiser Permanente Ventures LLC- Series A, Kaiser Permanente Ventures LLC – Series B and The Permanente Federation LLC – Series J shall be deemed
to be Affiliates of each other, and Julian Harvey Wood and Kaveh Sheibani shall each be deemed an Affiliate of Redmile. 
 “Board of
Directors” means the Board of Directors of the Company. 

 “BSC Percentage” means, at any time, (x) the number of Common Share
Equivalents owned by BSC at such time divided by (y) the number of Common Share Equivalents (as adjusted for stock splits, stock dividends and the like) owned by BSC as of immediately after the closing of the transactions
contemplated by the Series A Preferred Stock Purchase Agreement on March 28, 2008. 
 “BSC Warrant” means the
warrant for the purchase of Common Shares issued by the Company to BSC on March 28, 2008. 
 “Business Day”
means any day except a Saturday, Sunday or other day on which commercial banks in New York City are authorized by law to close. 

“Bylaws” means the Amended and Restated Bylaws of the Company, as amended from time to time. 

“Capital Royalty Warrants” means those certain warrants to purchase Common Stock of the Company issued to Capital Royalty
Partners II L.P. and Parallel Investment Opportunities Partners II L.P. (or affiliates thereof) on or about October 30, 2012. 

“Cause” means, with respect to any Person, that such Person (i) is convicted of or enters a plea of
guilty or nolo contendere to a felony, or to a crime or offense involving the property of the Company, any of its Subsidiaries or any of its other Affiliates, (ii) commits any act involving dishonesty, fraud or disloyalty, or breach of
his fiduciary duty to the Company or any of its Subsidiaries, which in any such case is of material detriment to the business, condition (financial or otherwise), reputation, character or standing of the Company or any of its Subsidiaries,
(iii) fails or is unable or unwilling for any reason to devote his full business time and attention to the affairs of the Company and its Subsidiaries (other than by reason of such Person’s death or permanent disability), following written
notice from the Board of Directors or any Sub Board of Directors and a failure to cure such conduct within 10 calendar days of receiving such notice, (iv) engages in gross negligence or willful misconduct with respect to his duties on behalf of
the Company or any of its Subsidiaries or (v) in the case of any Founder, breaches this Agreement, in any material respect, and such breach is not cured by such Founder promptly after receipt of notice thereof given by any of the Funds. 

 “Certificate of Incorporation” means the Amended and Restated Certificate of Incorporation of the Company, as
the same may be amended from time to time. 
 “Common Share Equivalent” shall be determined, as of any date, as
follows: (i) each Common Share shall have a Common Share Equivalent equal to one, (ii) each Series A Preferred Share, Series B Preferred Share, Series C Preferred Share, Series D Preferred Share, Series E Preferred Share and each
other security of the Company that is convertible into or exchangeable for Common Shares shall have a number of Common Share Equivalents equal to the number of Common Shares into or for which such Share or other security, as the case may be, is
convertible or exchangeable as of such date and (iii) each option, warrant or other right to acquire any shares of capital stock of the Company or any other equity or equity-linked security issued by the

 
Company (including the BSC Warrant) shall have a number of Common Share Equivalents equal to the maximum number of Common Shares issuable upon the exercise or conversion of any such Company
Security. 
 “Common Shares” means shares of Common Stock. 

“Common Stock” means the common stock, par value $0.01 per share, of the Company and any stock into which such Common
Stock may thereafter be converted or changed. 
 “Company Securities” means (i) the Common Stock,
(ii) the Series A Preferred Stock, (iii) the Series B Preferred Stock, (iv) the Series C Preferred Stock, (v) the Series D Preferred Stock, (vi) the Series E Preferred Stock, (vii) securities convertible into or
exchangeable for any shares of capital stock of the Company (including convertible indebtedness), (viii) any other equity or equity-linked security issued by the Company and (ix) options, warrants or other rights to acquire any shares of
capital stock of the Company or any other equity or equity-linked security issued by the Company (including the BSC Warrant). 

“Confidentiality Agreement” means the Confidential Disclosure Agreement dated as of March 28, 2008 between Boston
Scientific Corporation and the Company. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended.

 “FINRA” means the Financial Industry Regulatory Authority, Inc. 

“Fund Percentage” means with respect to any Fund (other than Pinnacle, KPV, Redmile, Deerfield, Rock Springs and Permal) at
any time, (x) the number of Common Share Equivalents owned by such Fund at such time divided by (y) the number of Common Share Equivalents (as adjusted for stock splits, stock dividends and the like) owned by such Fund as of
immediately after the closing of the transactions contemplated by the Series A Preferred Stock Purchase Agreement on March 28, 2008; provided, however, that with respect to Pinnacle, the term “Fund Percentage” means at any
time, (x) the number of Common Share Equivalents owned by Pinnacle at such time divided by (y) the number of Common Share Equivalents (as adjusted for stock splits, stock dividends and the like) owned by Pinnacle as of immediately
following the closing of the transactions contemplated by the Series C Preferred Stock Purchase Agreement dated June 30, 2010 (the “Series C Financing”); and provided, further, that with respect to each of KPV and
Redmile, the term “Fund Percentage” means at any time, (x) the number of Common Share Equivalents owned by KPV or Redmile, as applicable, at such time divided by (y) the number of Common Share Equivalents (as adjusted for
stock splits, stock dividends and the like) owned by KPV or Redmile, as applicable, as of immediately following the closing of all transactions contemplated by the Series D Purchase Agreement dated June 1, 2012 (the “Series D
Financing”); and, provided, further, that with respect to Deerfield, Rock Springs and Permal the term “Fund Percentage” means at any time, (x) the number of Common Share Equivalents owned by Deerfield, Rock Springs and
Permal, as applicable, at such time divided by (y) the number of Common Share Equivalents (as adjusted for stock splits, stock dividends and the like) owned by Deerfield, Rock Springs and Permal, as applicable, as of

 
immediately following the closing of the transactions contemplated by the Series E Purchase Agreement (the “Series E Financing”) 

“GAAP” means United States generally accepted accounting principles, as in effect from time to time. 

“Intellectual Property” shall have the meaning ascribed to such term in the Stock Purchase Agreement among the
Company, BSC and Boston Scientific Corporation, dated as of March 28, 2008, as follows: all rights in, to and concerning (a) patents, patent applications and statutory invention registrations (including divisionals, continuations, foreign
counterparts, re-issues and re-examinations thereof), (b) trademarks, service marks, trade dress, logos, trade names, corporate names (whether or not registered), domain names and other source identifiers (including all registrations,
applications for registration, extensions, modifications and renewals thereof) and all goodwill associated with any of the foregoing, (c) published and unpublished works of authorship, copyrights (whether or not registered) and applications for
registration thereof and all derivative works, moral rights, renewals, extensions, restorations and reversions thereof, (d) software, object code, source code, firmware, specifications, data, databases and compilations of information, and
(e) confidential and proprietary information, inventions, formulas, processes, developments, technology, research, trade secrets and know-how. 

“IPO” means the initial Public Offering after the date hereof. 

“Options” means stock options granted pursuant to any option or equity-based compensation plan adopted by the Company. 

“Permitted Transferee” means: 

(i) in the case of any Fund, (A) any Affiliate of such Fund, (B) any general or limited partner of such Fund (a
“Fund Partner”), (C) any current or former managing director, general partner, director, limited partner, officer or employee of such Fund or Fund Partner (collectively, “Fund Associates”), (D) the heirs,
executors, administrators, testamentary trustees, legatees or beneficiaries of any Fund Partner or Fund Associate and (E) a trust, corporation, partnership, or other entity substantially all the economic interests of which are held by or for
the benefit of such Fund, its Affiliates, Fund Partners, Fund Associates, their spouses or their children (whether by birth or adoption); 

(ii) with respect to BSC, (A) any Affiliate of BSC and (B) a trust, corporation, partnership or other entity
substantially all the economic interests of which are held by or for the benefit of BSC, or any Affiliate of BSC; 
 (iii) in
the case of any Stockholder that is an individual, (A) the issue or spouse of such Stockholder (x) by will or the laws of descent and distribution or (y) by gift without consideration of any kind and (B) a trust that is for the
exclusive benefit of such Stockholder or the issue or spouse of such Stockholder; or 

 (iv) in the case of any other Stockholder, any wholly-owned Subsidiary of such
Stockholder. 
 “Person” means an individual, corporation, limited liability company, partnership, association,
trust or other entity or organization, including a government or political subdivision or an agency or instrumentality thereof. 

“Pinnacle Common Stock Warrants” means those certain warrants to purchase Common Stock of the Company issued to
Pinnacle Ventures II Equity Holdings, L.L.C. and Pinnacle Ventures III Equity Holdings, L.L.C. (or affiliates thereof) on or about the closing date of the Series C Financing. 

“Pinnacle Preferred Stock Warrants” means those certain warrants to purchase Series C Preferred Stock of the Company
issued to Pinnacle Ventures II Equity Holdings, L.L.C. and Pinnacle Ventures III Equity Holdings, L.L.C. (or affiliates thereof) on or about the closing date of the Series C Financing. 

“Pinnacle Warrants” means the Pinnacle Common Stock Warrants and the Pinnacle Preferred Stock Warrants. 

“Pro Rata Portion” means, with respect to any Stockholder at any time, the fraction that results from dividing
(i) the number of Common Share Equivalents that such Stockholder owns at such time by (ii) the number of Common Share Equivalents owned by all of the Stockholders at such time. 

“Public Offering” means any underwritten public offering of common equity securities of the Company pursuant to an
effective registration statement under the Securities Act other than pursuant to a registration statement on Form S-4 or Form S-8 or any successor or similar form.

 “Qualified Holder” means BSC, any holder of Series A Preferred Shares, any holder of Series B Preferred
Shares, any holder of Series C Preferred Shares, any holder of Series D Preferred Shares and any holder of Series E Preferred Shares; provided that, at such time, BSC or such holder, together with its Permitted Transferees,
holds Common Share Equivalents representing at least 3% of the total number of Common Share Equivalents held by the Stockholders at such time. Solely for purposes of Section 5.02 of this Agreement, Qualified Holder also includes any Preferred
Stockholder that is a Qualified Holder as of immediately after the initial closing of the Series D Financing so long as such Preferred Stockholder, together with its Permitted Transferees, continues to hold at least 75% of the Common Share
Equivalents held by such Preferred Stockholder as of the initial closing of the Series D Financing.  
 “Qualifying
IPO” means a firm commitment, underwritten public offering of Common Shares pursuant to an effective registration statement filed under the Securities Act in which the aggregate gross proceeds to the Corporation (before underwriting
discounts, commission and fees) are no less than $35,000,000.  

 “Registrable Securities” means the Common Shares and the Common Shares
issuable or issued upon conversion of the Series A Preferred Shares, Series B Preferred Shares, Series C Preferred Shares, Series D Preferred Shares or Series E Preferred Shares or upon exercise of the BSC Warrant and, solely with respect to the
piggyback registration rights provided for in Section 4.02, the Pinnacle Preferred Stock Warrants, and any securities issued directly or indirectly with respect to the Common Shares by way of a split, dividend, or other division of securities,
or in connection with a combination of securities, recapitalization, merger, consolidation, or other reorganization. As to any particular Registrable Securities, such Registrable Securities shall cease to be Registrable Securities when they have
been (i) effectively registered under the Securities Act and disposed of in accordance with the applicable registration statement, (ii) sold pursuant to Rule 144 or (iii) repurchased by the Company or otherwise cease to be
outstanding. 
 “Registration Expenses” means any and all expenses incident to the performance of or
compliance with any registration or marketing of securities, including all (i) registration and filing fees, and all other fees and expenses payable in connection with the listing of securities on any securities exchange or automated
interdealer quotation system, (ii) fees and expenses of compliance with any securities or “blue sky” laws (including reasonable fees and disbursements of counsel in connection with “blue sky” qualifications of the securities
registered), (iii) expenses in connection with the preparation, printing, mailing and delivery of any registration statements, prospectuses and other documents in connection therewith and any amendments or supplements thereto,
(iv) security engraving and printing expenses, (v) internal expenses of the Company (including all salaries and expenses of its officers and employees performing legal or accounting duties), (vi) reasonable fees and disbursements of
counsel for the Company and customary fees and expenses for independent certified public accountants retained by the Company (including the expenses relating to any comfort letters or costs associated with the delivery by independent certified
public accountants of any comfort letters requested pursuant to Section 4.04(h)), (vii) reasonable fees and expenses of any special experts retained by the Company in connection with such registration, (viii) reasonable fees,
out-of-pocket costs and expenses of the Stockholders, including one counsel for all of the Stockholders participating in the offering selected (A) by the Funds, in the case of any offering in which such Funds participate, or (B) in any
other case, by the Stockholders holding the majority of the Registrable Securities to be sold for the account of all Stockholders in the offering, (ix) fees and expenses in connection with any review by the FINRA of the underwriting
arrangements or other terms of the offering, and all fees and expenses of any “qualified independent underwriter,” including the fees and expenses of any counsel thereto, (x) fees and disbursements of underwriters customarily paid by
issuers or sellers of securities, but excluding any underwriting fees, discounts and commissions attributable to the sale of Registrable Securities, (xi) costs of printing and producing any agreements among underwriters, underwriting
agreements, any “blue sky” or legal investment memoranda and any selling agreements and other documents in connection with the offering, sale or delivery of the Registrable Securities, (xii) transfer agents’ and registrars’
fees and expenses and the fees and expenses of any other agent or trustee appointed in connection with such offering, (xiii) expenses relating to any analyst or investor presentations or any “road shows” undertaken in connection with
the registration, marketing or selling of the Registrable Securities, (xiv) fees and expenses payable in connection with any ratings of the Registrable Securities, including expenses relating 

 
to any presentations to rating agencies and (xv) all out-of pocket costs and expenses incurred by the Company or its appropriate officers in connection with their compliance with
Section 4.04(m). 
 “ROFO Portion” means, with respect to any Accepting Holder at any time, the fraction that results
from dividing (i) the number of Common Share Equivalents that such Accepting Holder owns at such time by (ii) the number of Common Share Equivalents owned by all of the Accepting Holders at such time. 

“Rule 144” means Rule 144 and Rule 144A (or any successor provisions) under the Securities Act. 

“Sale of the Company” means (i) a liquidation, dissolution or winding up of the Company, (ii) the acquisition of
the Company by another entity by means of any transaction or series of related transactions (including, without limitation, any reorganization, merger or consolidation other than any merger effected exclusively for the purpose of changing the
domicile of the Company) or a sale of all or substantially all of the assets of the Company unless, in the case of any such transaction or sale, the Company’s stockholders of record as constituted immediately prior to such transaction or
sale will, immediately after such transaction or sale (by virtue of securities issued as consideration for the Company’s securities or otherwise) hold at least fifty percent (50%) of the voting power of the surviving or acquiring entity or
an entity controlling such surviving or acquiring entity in the same proportions among such stockholders as held by them immediately prior to such transaction or (iii) a transaction or series of transactions in which a person or group of
persons (as defined in Rule 13d-5(b)(1) of the Exchange Act) acquires beneficial ownership (as determined in accordance with Rule 13d-3 of the Exchange Act) of more than fifty percent (50%) of the voting power of the Company, provided
that in the case of this clause (iii) no persons shall be deemed to constitute such a group solely by virtue of complying with this Agreement. 

“SEC” means the Securities and Exchange Commission. 

“Section 3.06 Portion” means, with respect to any Section 3.06 Accepting Holder at any time, the fraction that results
from dividing (i) the number of Common Share Equivalents that such Section 3.06 Accepting Holder owns at such time by (ii) the number of Common Share Equivalents owned by all of the Section 3.06 Accepting Holders at such
time. 
 “Securities Act” means the Securities Act of 1933, as amended. 

“Series A Preferred Shares” means shares of Series A Preferred Stock. 

“Series A Preferred Stock” means the Series A Preferred Stock, par value $0.01 per share, of the Company. 

“Series B Preferred Shares” means shares of Series B Preferred Stock. 

 “Series B Preferred Stock” means the Series B Preferred Stock, par value
$0.01 per share, of the Company. 
 “Series C Preferred Shares” means shares of Series C Preferred Stock. 

“Series C Preferred Stock” means the Series C Preferred Stock, par value $0.01 per share, of the Company. 

“Series D Preferred Shares” means shares of Series D Preferred Stock. 

“Series D Preferred Stock” means the Series D Preferred Stock, par value $0.01 per share, of the Company. 

“Series D Warrants” means those certain warrants to purchase Series D Preferred Stock of the Company. 

“Series E Preferred Shares” means shares of Series E Preferred Stock. 

“Series E Preferred Stock” means the Series E Preferred Stock, par value $0.01 per share, of the Company. 

“Shares” means the Common Shares, the Series A Preferred Shares, the Series B Preferred Shares, the Series C Preferred
Shares, the Series D Preferred Shares and the Series E Preferred Shares and any other shares of the capital stock of the Company issued on or after the date of this Agreement. 

“Stockholder” means at any time, any Person (other than the Company) who shall then be a party to or bound by this Agreement,
so long as such Person shall “beneficially own” (as such term is defined in Rule 13d-3 of the Exchange Act) any Company Securities. 

“Sub Board of Directors” means the Board of Directors of each Subsidiary of the Company formed under the laws of the United
States. 
 “Subsidiary” means, with respect to any Person, any entity of which securities or other ownership interests
having ordinary voting power to elect a majority of the board of directors or other persons performing similar functions are at the time directly or indirectly owned by such Person. 

“Tag-Along Portion” means, with respect to any Tag-Along Seller at any time, the number of Common Share Equivalents that such
Tag-Along Seller owns at such time multiplied by a fraction the numerator of which is the maximum number of Common Share Equivalents proposed to be Transferred by the Selling Holder in such Tag-Along Sale and the denominator of which is the
total number of Common Share Equivalents owned by all of the Stockholders at such time. 

 “Transfer” means, with respect to any Company Securities, (i) when used as
a verb, to sell, assign, dispose of, exchange, pledge, encumber, hypothecate or otherwise transfer such Company Securities or any participation or interest therein, whether directly or indirectly, or agree or commit to do any of the foregoing and
(ii) when used as a noun, a direct or indirect sale, assignment, disposition, exchange, pledge, encumbrance, hypothecation, or other transfer of such Company Securities or any participation or interest therein or any agreement or commitment to
do any of the foregoing. 
 (b) Each of the following terms is defined in the Section set forth opposite such term: 

 

			
	 Term
	  	 
	Accepting Holder	  	Section 3.05(b)
	Additional Stockholders	  	Preamble
	BSC	  	Preamble
	BSC Offer	  	Section 3.06(b)
	BSC Offer Expiration Date	  	Section 3.06(b)
	BSC Offer Notice	  	Section 3.06(a)
	BSC Offer Price	  	Section 3.06(a)
	BSC Offered Securities	  	Section 3.06(a)
	BSC Proposed Purchaser	  	Section 3.06(a)
	BSC Sale Price	  	Section 3.06(b)
	BSC Unaccepted Securities	  	Section 3.06(d)
	Common Legacy Stockholders	  	Preamble
	Company	  	Preamble
	Company Offer Period	  	Section 3.05(b)
	Confidential Information	  	Section 5.01(b)
	Damages	  	Section 4.05
	Deerfield	  	Preamble
	Delphi	  	Preamble
	Demand Registration	  	Section 4.01(a)
	Distribution in Kind	  	Section 3.01(a)
	Drag-Along Holder	  	Section 3.08(a)
	Drag-Along Offer	  	Section 3.08(a)
	Drag-Along Purchaser	  	Section 3.08(a)
	Drag-Along Notice	  	Section 3.08(b)
	Dragging Holders	  	Section 3.08(a)
	Founders	  	Preamble
	Funds	  	Preamble
	Indemnified Party	  	Section 4.07
	Indemnifying Party	  	Section 4.07
	Inspectors	  	Section 4.04(g)
	KPV	  	Preamble
	Legacy Stockholders	  	Preamble
	Lock-Up Period	  	Section 4.03
	Maximum Offering Size	  	Section 4.01(e)

			
	MPM	  	Preamble
	NEA	  	Preamble
	 Next Financing
 Offer
	  	 Section 2.01(d)
 Section 3.05(b)

	Offered Securities	  	Section 3.05(b)
	Offer Notice	  	Section 3.05(a)
	Offer Expiration Date	  	Section 3.05(b)
	Offer Price	  	Section 3.05(a)
	Permal	  	Preamble
	Piggyback Registration	  	Section 4.02(a)
	Preferred Stockholder	  	Preamble
	Proposed Purchaser	  	Section 3.05(a)
	Prospective Seller	  	Section 3.05(a)
	Records	  	Section 4.04(g)
	Redmile	  	Preamble
	Registering Stockholders	  	Section 4.01(a)
	Representatives	  	Section 5.01(b)
	Requesting Stockholder	  	Section 4.01(a)
	Rock Springs	  	Preamble
	Section 3.04 Acceptance	  	Section 3.04(a)
	Section 3.04 Notice	  	Section 3.04(a)
	Section 3.05 Acceptance	  	Section 3.05(b)
	Section 3.06 Acceptance	  	Section 3.06(b)
	Section 3.06 Accepting Holder	  	Section 3.06(b)
	Selling Holder	  	Section 3.07(a)
	Series E Purchase Agreement	  	Recitals
	Tag-Along Notice	  	Section 3.07(a)
	Tag-Along Notice Period	  	Section 3.07(b)
	Tag-Along Purchaser	  	Section 3.07(a)
	Tag-Along Response Notice	  	Section 3.07(b)
	Tag-Along Sale	  	Section 3.07(a)
	Tag-Along Seller	  	Section 3.07(b)
	Transfer Date	  	Section 3.07(d)
	TWK	  	Preamble
	Unaccepted Securities	  	Section 3.05(d)

 Section 1.02 Other Definitional and Interpretative Provisions. The words “hereof,”
“herein” and “hereunder” and words of like import used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. The captions herein are included for convenience of
reference only and shall be ignored in the construction or interpretation hereof. References to Articles, Sections, Exhibits and Schedules are to Articles, Sections, Exhibits and Schedules of this Agreement unless otherwise specified. All Exhibits
and Schedules annexed hereto or referred to herein are hereby incorporated in and made a part of this Agreement as if set forth in full herein. Any capitalized terms used in any Exhibit or Schedule 

 
but not otherwise defined therein, shall have the meaning as defined in this Agreement. Any singular term in this Agreement shall be deemed to include the plural, and any plural term the
singular. Whenever the words “include,” “includes” or “including” are used in this Agreement, they shall be deemed to be followed by the words “without limitation,” whether or not they are in fact followed by
those words or words of like import. “Writing,” “written” and comparable terms refer to printing, typing and other means of reproducing words (including electronic media) in a visible form. References to any agreement or contract
are to that agreement or contract as amended, modified or supplemented from time to time in accordance with the terms hereof and thereof; provided that with respect to any agreement or contract listed on any schedules hereto, all such
amendments, modifications or supplements must also be listed in the appropriate schedule. References to any Person include the successors and permitted assigns of that Person. References from or through any date mean, unless otherwise specified,
from and including or through and including, respectively. 
 ARTICLE 2 

CORPORATE GOVERNANCE 

Section 2.01 Composition of the Board of Directors. (a) Prior to an IPO, the Board of Directors shall consist of eleven
directors, to be designated as follows: (i) one director shall be designated by each of MPM, Delphi, TWK, Pinnacle and KPV, with respect to each such Fund, for as long as the Fund Percentage of such Fund is at least 50%, and with respect to
KPV, subject to the conditions set forth in Section 2.01(d), (ii) two directors shall be designated by NEA for so long as the Fund Percentage of such Fund is at least 50%, (iii) one of the directors shall be the then Chief Executive
Officer of the Company, (iv) two of the directors shall each be a Person who shall not be either an “Affiliate” or an “Associate” (as such terms are used within the meaning of Rule 12b-2 under the Exchange Act) of the
Company, as designated by the unanimous resolution or written consent of the directors referred to in clauses (i) and (ii) above, and (v) one of the directors shall be a Person designated by a majority vote of the directors referred
to in clauses (i), (ii), (iii) and (iv) above. 
 (b) Each Stockholder agrees that, if at any time it is then entitled to vote for
the election of directors to the Board of Directors, it shall vote its Shares or execute proxies or written consents, as the case may be, and take all other necessary action (including causing the Company to call a special meeting of Stockholders)
in order to ensure that the composition of the Board of Directors is as set forth in this Section 2.01. 
 (c) The Company agrees to
cause each individual designated pursuant to Section 2.01(a) or Section 2.03 to be nominated to serve as a director on the Board of Directors, and to take all other necessary actions (including calling a special meeting of the Board of
Directors and/or Stockholders) to ensure that the composition of the Board of Directors is as set forth in this Section 2.01. 

Section 2.02 Removal. Any director designated by any Stockholder(s) pursuant to Section 2.01 or Section 2.03 will be
removed from the Board of Directors or a Sub Board of 

 
Directors, with or without Cause, at the written request of the Stockholder(s) entitled to designate such director; and, subject to Section 141(k) of the Delaware General Corporation Law,
under no other circumstances. Upon such request, each Stockholder agrees to vote its Shares or execute proxies or written consents, as the case may be, for the removal of such director. 

Section 2.03 Vacancies. In the event any director ceases to serve as a member of the Board of Directors or a Sub Board of
Directors during his or her term of office, or for any other reason there are at any time fewer designees serving on the Board of Directors than are entitled to be designated by a Stockholder, the resulting vacancy on the Board of Directors or the
Sub Board of Directors may be filled at any time (i) by a designee designated by the Stockholder or Stockholders entitled to designate such vacant Board of Directors seats and may not be filled by any other Person and (ii) if no
Stockholder is entitled to designate a designee to fill such vacancy at such time, then in the manner set forth in the Bylaws of the Company. 

Section 2.04 Committees. Committees of the Board of Directors or a Sub Board of Directors shall be created only upon the approval
of a majority of the members of the entire Board of Directors or a majority of the members of the entire Sub Board of Directors, in each case, assuming there were no vacancies and provided that action is taken at a meeting at which a quorum exists
or by unanimous written consent, and the composition of each such committee (including the audit committee and the compensation committee), shall be proportionately equivalent to that of the Board of Directors (to the extent practicable), and in any
event shall contain at least two directors designated pursuant to Section 2.01(a)(i) or (ii). 
 Section 2.05 Director
Expenses; Directors’ and Officers’ Insurance; Indemnity and Exculpation. The Company or its Subsidiaries shall pay all of the reasonable out-of-pocket expenses incurred by each director in connection with attending the meetings of the
Board of Directors, any Sub Board of Directors and any committee thereof. For so long as any member designated under this Agreement serves on the Board of Directors or a Sub Board of Directors and for six years thereafter, (i) the Company and
its Subsidiaries shall maintain directors and officers indemnity insurance coverage satisfactory to the Board of Directors and such Sub Board of Directors at the time such insurance is first obtained and such insurance shall not thereafter be
reduced in amount or coverage without the approval of a majority of the Board of Directors, including at least two directors designated pursuant to Sections 2.01(a)(i) or (ii), above, and (ii) the Company’s and its Subsidiaries’
certificates of incorporation and bylaws shall provide for indemnification and exculpation of members to the fullest extent permitted under applicable law. 

Section 2.06 Agreement to Implement the Foregoing. Each party hereto agrees that it will vote its Shares or execute consents, as
the case may be, and each party hereto (including the Company) shall take all other necessary action (including nominating such designees and calling an annual or special meeting of stockholders) in order to ensure that the composition of the Board
of Directors and each Sub Board of Directors is as set forth in this ARTICLE 2 and otherwise to give effect to the provisions of this ARTICLE 2. Each party shall vote its Shares, and shall take all other actions necessary, to ensure that the
Certificate of Incorporation and Bylaws of the Company and each of its Subsidiaries facilitate and do not at any time conflict with any provision of this Agreement. 

 Section 2.07 No Liability for Election of Recommended Director. None of the
Funds nor any Fund Partner or Fund Associate makes any representation or warranty as to the fitness or competence of the nominee of any Fund to serve on the Board of Directors by virtue of such Fund’s execution of this Agreement or by the act
of such Fund in voting for such nominee pursuant to this Agreement. 
 Section 2.08 Irrevocable Proxy. To secure each
Stockholder’s obligations to vote the Shares in accordance with this Agreement, each Stockholder hereby appoints the Chairman of the Board of Directors or the Chief Executive Officer of the Company, or either of them from time to time, or their
designees, as Stockholder’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to vote all of such Stockholder’s Shares as specifically set forth in this Agreement and to execute all
appropriate instruments consistent with this Agreement on behalf of such Stockholder if, and only if, such Stockholder fails to vote all of such Stockholder’s Shares or execute such other instruments in accordance with the provisions of this
Agreement within five (5) days of the Company’s or any other party’s written request for such Stockholder’s written consent or signature. The proxy and power granted by each Stockholder pursuant to this Section are coupled with
an interest and are given to secure the performance of such party’s duties under this Agreement. Each such proxy and power will be irrevocable for the term hereof. The proxy and power, so long as any party hereto is an individual, will survive
the death, incompetency and disability of such party or any other individual holder of the Shares and, so long as any party hereto is an entity, will survive the merger or reorganization of such party or any other entity holding any Shares. 

Section 2.09 Termination/Amendment. This ARTICLE 2 shall continue in full force and effect from the date hereof through the
earlier of the following dates, on which date such Article shall terminate in their entirety: 
 (a) the date of the closing of an IPO; or

 (b) the date of the closing of a Sale of the Company. 

ARTICLE 3 

RIGHTS AND OBLIGATIONS WITH RESPECT TO
TRANSFER; 
 PREEMPTIVE RIGHTS 

Section 3.01 General Restrictions. (a) No Stockholder (other than BSC) may Transfer any Company Securities or any
interest therein, except (i) to a Permitted Transferee of such Stockholder, (ii) pursuant to an exercise of registration rights in accordance with ARTICLE 4, (iii) pursuant to Rule 144, (iv) as a Prospective Seller pursuant to
Section 3.05, a Selling Holder or a Tag-Along Seller pursuant to Section 3.07 or a Dragging Holder or a Drag-Along Holder pursuant to Section 3.08, or (v) pursuant to a Transfer by any Fund that is a partnership or limited
liability company of any of its Company Securities to any Fund Partner pursuant to a distribution that is made pro rata to such Fund Partner in accordance with the respective 

 
partnership or limited liability company agreement of such Fund without payment of additional consideration therefor by such Partner (a “Distribution in Kind”). 

(b) BSC may not Transfer any Company Securities or any interest therein, except (i) to a Permitted Transferee of BSC, (ii) pursuant
to an exercise of registration rights in accordance with ARTICLE 4, (iii) pursuant to Rule 144, (iv) pursuant to Section 3.06, or (v) as a Tag-Along Seller pursuant to Section 3.07 or a Dragging Holder or a Drag-Along Holder
pursuant to Section 3.08. 
 (c) Notwithstanding anything herein to the contrary, each Transfer of Company Securities must be made in
compliance with the Securities Act and any applicable state and foreign securities laws. Each Stockholder understands and agrees that the Company Securities owned by the Stockholders on the date of this Agreement have not been registered under the
Securities Act and are restricted securities. Any attempt to Transfer any Company Securities not in compliance with this Agreement shall be null and void and neither the Company nor any transfer agent shall give any effect in the Company’s
transfer records to such Transfer. 
 (d) No Stockholder shall enter into any agreement or arrangement of any kind with any Person with
respect to its Company Securities inconsistent with the provisions of this Agreement, including agreements or arrangements with respect to the acquisition, disposition or voting of its Company Securities. 

Section 3.02 Agreement to be Bound. No Transfer of Company Securities otherwise permitted pursuant to this ARTICLE 3 (other than
Transfers pursuant to an exercise of registration rights in accordance with ARTICLE 4 or to the Company, or Transfers made under Rule 144 following an IPO) shall be effective unless (i) the certificates or instruments representing such Company
Securities delivered to the transferee shall bear the legends set forth in Section 3.03, if required by such Section and (ii) prior to such Transfer, the transferee (if not already a party to this Agreement) shall have executed and
delivered to the Company an instrument or instruments substantially in the form of Exhibit D hereto confirming that such transferee has agreed to be bound, as an “Additional Stockholder,” “Preferred Stockholder,”
“Fund,” “BSC,” “Legacy Stockholder” and/or “Founder,” as the case may be, by the terms of this Agreement, a copy of which instrument shall be maintained on file with the Secretary of the Company and shall
include the address of such transferee to which notices hereunder shall be sent; provided that the provisions of clause (ii) above shall not be applied to any Distribution in Kind in connection with which the Fund effecting such
Distribution in Kind determines not to require the distributees to have agreed in writing to be bound by the terms of this Agreement or to be entitled to the benefit hereof. The Company agrees that prior to issuing Common Shares to any holder of any
Options, the BSC Warrant, the Pinnacle Warrants or the Capital Royalty Warrants, the Company will require such holder to agree to be bound by this Agreement in the manner described above. 

Section 3.03 Legends. (a) Each certificate or instrument evidencing outstanding Company Securities shall bear legends in
substantially the following form: 

 THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD, OR TRANSFERRED EXCEPT IN COMPLIANCE THEREWITH. 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE ALSO SUBJECT TO ADDITIONAL RESTRICTIONS, INCLUDING RESTRICTIONS ON TRANSFER,
AS SET FORTH IN A STOCKHOLDERS’ AGREEMENT, A COPY OF WHICH WILL BE FURNISHED BY TV2 HOLDING COMPANY UPON REQUEST AND WITHOUT CHARGE. 

Notwithstanding the foregoing, the Company shall be obligated to reissue promptly unlegended certificates at the request of any holder thereof
if the Company has completed an IPO and the Stockholder shall have obtained an opinion of counsel (which counsel may be counsel to the Company) reasonably acceptable to the Company to the effect that the securities proposed to be disposed of may
lawfully be so disposed of without registration, qualification and legend; provided that the second legend listed above shall be removed only at such time as the holder of such certificate is no longer subject to any restrictions hereunder.

 Section 3.04 Preemptive Rights. (a) Except as provided in Section 3.04(e), the Company shall provide each
Qualified Holder with a written notice (a “Section 3.04 Notice”) of any proposed issuance of Company Securities at least 30 calendar days prior to the proposed issuance date. Such Section 3.04 Notice shall specify the identity
of the Person to whom, and the price at which, such Company Securities are proposed to be issued and all other material terms thereof. Subject to Section 3.04(e), each Qualified Holder shall be entitled to purchase, at the price and on the
terms specified in such Section 3.04 Notice, the number (or amount) of such Company Securities equal to such Qualified Holder’s Pro Rata Portion (immediately before giving effect to such issuance) of the proposed issuance. 

(b) A Qualified Holder may exercise its rights under this Section 3.04 by delivering written notice of its election to purchase Company
Securities to the Company within 15 Business Days of the effective date of the Section 3.04 Notice (a “Section 3.04 Acceptance”). The Company shall promptly deliver a copy of such Section 3.04 Acceptance to each other
Qualified Holder. Delivery of a Section 3.04 Acceptance by any Qualified Holder shall constitute a binding agreement of such Qualified Holder to purchase, at the price and on the terms specified in the Section 3.04 Notice, the number (or
amount) of Company Securities specified in such Qualified Holder’s Section 3.04 Acceptance. If at the termination of such 15 Business Day period any Qualified Holder shall not have exercised its rights to purchase any portion of such
Company Securities, such Qualified Holder will be deemed to have waived any and all of its rights under this Section 3.04 with respect to the purchase of such Company Securities. If any Qualified Holder fails to exercise its preemptive rights
under this Section 3.04 or elects to exercise such rights with respect to less than such Qualified Holder’s Pro Rata Portion, the Company shall notify each other Qualified Holder which has delivered a Section 3.04 Acceptance to
exercise its rights to purchase its entire Pro Rata Portion, that such Qualified 

 
Holder shall be entitled to purchase from the Company its pro rata portion (which means the fraction that results from dividing (i) the number of Common Share Equivalents that such Qualified
Holder owns at such time by (ii) the number of Common Share Equivalents owned by all Qualified Holders exercising in full their rights under this Section 3.04 with respect to their respective Pro Rata Portions) of such Company Securities
with respect to which no Qualified Holder shall have exercised its rights under this Section 3.04. The Company shall continue to offer additional pro rata portions to Qualified Holders choosing to purchase their full pro rata portion of such
Company Securities pursuant to this Section 3.04(b) until (i) all Company Securities proposed to be issued by the Company and with respect to which Stockholders were entitled to exercise their rights under this Section 3.04 have been
purchased by Qualified Holders or (ii) all Qualified Holders have purchased the maximum number of Company Securities indicated in their respective Section 3.04 Acceptances, whichever is earlier. 

(c) The Company shall have 120 calendar days from the effective date of the Section 3.04 Notice to consummate the proposed issuance of
any or all of such Company Securities which the Qualified Holders have not elected to purchase at the price and upon terms that are no less favorable to the Company than those specified in the Section 3.04 Notice; provided that if such
issuance is subject to regulatory approval, such 120-day period shall be extended until the expiration of five Business Days after all such approvals have been received, but in no event later than an additional 90 calendar days following the
expiration of such 120-day period. The closing of purchases of Company Securities by Qualified Holders exercising their preemptive rights under this Section 3.04 shall take place on the closing date of such issuance. At such closing, the
Company shall issue certificates representing the Company Securities to be purchased by each Qualified Holder exercising preemptive rights pursuant to this Section 3.04 registered in the name of such Qualified Holder, against payment by such
Qualified Holder of the purchase price for such Company Securities by wire transfer or bank or certified check (in immediately available funds). If the Company shall not have consummated such proposed issuance within the period described above, then
the Company’s rights to sell such Company Securities, and the rights of the Qualified Holders to purchase such Company Securities pursuant to this Section 3.04, shall terminate and the Company shall again comply with the procedures set
forth in this Section 3.04 with respect to any proposed issuance of such Company Securities. 
 (d) Notwithstanding anything in this
Agreement to the contrary, each Fund shall have the right to assign its rights under this Section 3.04 to one or more of its Affiliates. 

(e) The provisions of this Section 3.04 shall not apply to any proposed issuance of Company Securities excluded from the definition of
“Additional Securities” under Section 4.02(d)(iii)(B)(1) through (9) of the Certificate of Incorporation (expressly excluding the exception set forth in Section 4.02(d)(iii)(B)(10) of the Certificate of Incorporation). The
provisions of this Section 3.04 shall terminate upon the consummation of an IPO. 
 Section 3.05 Rights of First Offer.
(a) Except as provided in Section 3.05(e) and subject to Section 3.01, if (i) any Preferred Stockholder, (ii) any Founder, or (iii) any other Stockholder (for the avoidance of doubt, other than BSC) who is a current or
former employee or consultant of the Company or any of its Subsidiaries and who, together with his or her Permitted 

 
Transferees, holds Company Securities representing at least 1% of the then outstanding Common Share Equivalents proposes to Transfer (a “Prospective Seller”) any Company
Securities to any Person (a “Proposed Purchaser”), in a bona fide, arm’s-length transaction or series of related transactions, such Prospective Seller shall provide written notice (the “Offer Notice”) of such
proposed Transfer to the Company and each of the Funds, setting forth the identity of the Proposed Purchaser, the number and kind of Company Securities proposed to be Transferred by such Prospective Seller (the “Offered
Securities”), the purchase price per security that such Prospective Seller proposes to be paid for such Offered Securities (the “Offer Price”) (which shall be payable solely in cash in one lump sum payment) and all other
material terms sought by the Prospective Seller, including the form of any proposed agreement with the Proposed Purchaser, if any. 

(b) The receipt of an Offer Notice by the Company and the Funds shall constitute an irrevocable offer (an “Offer”) by
such Prospective Seller to Transfer the Offered Securities to the Company (and thereafter to such Funds as provided herein) for cash at the Offer Price and on the other terms set forth in the Offer Notice. The Company upon receipt of such Offer
Notice shall have a 15 Business Day period (the “Company Offer Period”) in which to accept such Offer as to all or any portion of the Offered Securities by giving a notice of acceptance to such Prospective Seller (together with a
copy thereof to the Funds) prior to the expiration of such Company Offer Period. If the Company fails to notify the Prospective Seller and the Funds prior to the expiration of the Company Offer Period, it shall be deemed to have declined such Offer.
If the Company declines (or is deemed to decline) such Offer with respect to all or any portion of the Offered Securities, the Company shall immediately provide written notice to the Funds thereof (the “Company Decline Notice”).
Each Fund shall then be entitled to accept the Offer (each Fund accepting such Offer, an “Accepting Holder”) with respect to its ROFO Portion of the number of Offered Securities that the Company has declined (or is deemed to have
declined) to purchase by giving written notice of acceptance to such Prospective Seller within 15 Business Days after receipt of the Company Decline Notice (a “Section 3.05 Acceptance”). If any Fund fails to exercise its rights
under this Section 3.05(b) or elects to exercise such rights with respect to less than such Fund’s ROFO Portion, the Company shall notify each other Accepting Holder which has delivered a Section 3.05 Acceptance to exercise its rights
to purchase its entire ROFO Portion, that such Fund shall be entitled to purchase from the Prospective Seller its pro rata portion (which means the fraction that results from dividing (i) the number of Common Share Equivalents that such
Accepting Holder owns at such time by (ii) the number of Common Share Equivalents owned by all Accepting Holders exercising in full their rights under this Section 3.05 with respect to their respective ROFO Portions)
of such Offered Securities with respect to which any Funds shall not have exercised its rights in full under this Section 3.05. The Company shall continue to offer additional pro rata portions to Accepting Holders choosing to purchase their
full pro rata portion of such Offered Securities pursuant to this Section 3.05(b) until (i) all Offered Securities have been purchased by the Accepting Holders or (ii) all Accepting Holders have purchased the maximum number of Offered
Securities indicated in their respective Section 3.05 Acceptances, whichever is earlier (the “Offer Expiration Date”). 

(c) If the Company and/or the Accepting Holders elect to purchase all or any of the Offered Securities, the Company and/or the Accepting
Holders, as the case may be, shall 

 
purchase and pay to the Prospective Seller the Offer Price, by wire transfer or bank or certified check (in immediately available funds), for all Offered Securities so accepted, within 10
Business Days after the Offer Expiration Date, provided that, if the Transfer of such Offered Securities is subject to regulatory approval the time period during which such Transfer may be consummated shall be extended until the expiration of
five Business Days after all such approvals shall have been received, but in no event shall such period be extended for more than an additional 90 calendar days after the Offer Expiration Date. 

(d) Upon the earlier to occur of (i) full rejection of the Offer by all recipients thereof, (ii) the Company and/or the
Accepting Holders not electing to purchase all of the Offered Securities as of the Offer Expiration Date, and (iii) the failure to obtain any required consent or regulatory approval for the purchase of any of any Offered Securities by the
Company and/or the Accepting Holders within 90 calendar days after the Offer Expiration Date, subject to Section 3.07, the Prospective Seller shall have a 120-day period during which to effect a Transfer of any or all of the Offered Securities
not elected to be purchased by the Company and/or the Funds or in respect of which any required consent or regulatory approval shall not have been obtained pursuant to clause (iii) above (collectively, the “Unaccepted
Securities”), on substantially the same or more favorable (as to the Prospective Seller) terms and conditions as were set forth in the Offer Notice at a price in cash not less than the Offer Price; provided that, if the
Transfer is subject to regulatory approval, such 120-day period shall be extended until the expiration of five Business Days after all such approvals shall have been received, but in no event shall such period be extended for more than an additional
90 calendar days. If the Prospective Seller does not consummate the Transfer of the Unaccepted Securities in accordance with the foregoing time limitations, then the right of the Prospective Seller to effect the Transfer of such Unaccepted
Securities pursuant to this Section 3.05(d) shall terminate and the Prospective Seller shall again comply with the procedures set forth in this Section 3.05 and Section 3.07 with respect to any proposed Transfer of Company Securities
to any Person. 
 (e) The provisions of this Section 3.05 shall not apply to any proposed Transfer of Company Securities by any
Stockholder (i) pursuant to a Public Offering or Rule 144, (ii) to the Company pursuant to a redemption or repurchase of any Company Securities in accordance with the terms thereof, (iii) to a Permitted Transferee of such Stockholder
or Stockholders or (iv) pursuant to Section 3.08. The provisions of this Section 3.05 shall terminate upon the consummation of an IPO or a Sale of the Company. 

Section 3.06 Prospective BSC Sale. (a) Except as provided in Section 3.06(e) and subject to Section 3.01, if BSC
proposes to Transfer any Company Securities to any Person (a “BSC Proposed Purchaser”), in a bona fide, arm’s-length transaction or series of related transactions, BSC shall provide written notice (the “BSC Offer
Notice”) of such proposed Transfer to the Company and each of the Funds, setting forth the identity of the BSC Proposed Purchaser, the number and kind of Company Securities proposed to be Transferred by BSC (the “BSC Offered
Securities”), the purchase price per security that such Prospective Seller proposes to be paid for such BSC Offered Securities (the “BSC Offer Price”) (which shall be payable solely in cash in one lump sum payment) and all
other material terms sought by BSC, including the form of any proposed agreement with the BSC Proposed Purchaser, if any. 

 (b) The receipt of a BSC Offer Notice by the Company and the Funds shall constitute an
irrevocable offer (a “BSC Offer”) by BSC to Transfer all, but not less than all, of the BSC Offered Securities to the Funds for an amount per share in cash (the “BSC Sale Price”) equal to the BSC Offer Price and on
the other terms set forth in the BSC Offer Notice. Each Fund shall then be entitled to accept the BSC Offer (each Fund accepting such Offer, a “Section 3.06 Accepting Holder”) with respect to its Section 3.06 Portion of the BSC
Offered Securities by giving written notice of acceptance to BSC within 30 Business Days after receipt of the BSC Offer Notice (a “Section 3.06 Acceptance”). If any Fund fails to exercise its rights under this Section 3.06(b)
or elects to exercise such rights with respect to less than such Fund’s Section 3.06 Portion, the Company shall notify each other Section 3.06 Accepting Holder which has delivered a Section 3.06 Acceptance to exercise its rights
to purchase its entire Section 3.06 Portion, that such Fund shall be entitled to purchase from BSC its pro rata portion (which means the fraction that results from dividing (i) the number of Common Share Equivalents that such
Section 3.06 Accepting Holder owns at such time by (ii) the number of Common Share Equivalents owned by all Section 3.06 Accepting Holders exercising in full their rights under this Section 3.06 with respect
to their respective Section 3.06 Portions) of such BSC Offered Securities with respect to which any Funds shall not have exercised its rights in full under this Section 3.06. The Company shall continue to offer additional pro rata portions
to Section 3.06 Accepting Holders choosing to purchase their full pro rata portion of such BSC Offered Securities pursuant to this Section 3.06(b) until (i) all BSC Offered Securities have been purchased by the Section 3.06
Accepting Holders or (ii) all Section 3.06 Accepting Holders have purchased the maximum number of BSC Offered Securities indicated in their respective Section 3.06 Acceptances, whichever is earlier (the “BSC Offer Expiration
Date”). 
 (c) If the Section 3.06 Accepting Holders elect to purchase all or any of the BSC Offered Securities, the
Section 3.06 Accepting Holders shall purchase and pay to BSC the BSC Sale Price, by wire transfer or bank or certified check (in immediately available funds), for all BSC Offered Securities so accepted, within 10 Business Days after the BSC
Offer Expiration Date, provided that, if the Transfer of such BSC Offered Securities is subject to regulatory approval the time period during which such Transfer may be consummated shall be extended until the expiration of five Business Days
after all such approvals shall have been received, but in no event shall such period be extended for more than an additional 90 calendar days after the BSC Offer Expiration Date. 

(d) Upon the earliest to occur of (i) full rejection of the BSC Offer by all recipients thereof, (ii) the Funds not electing to
purchase all of the BSC Offered Securities as of the BSC Offer Expiration Date, and (iii) the failure to obtain any required consent or regulatory approval for the purchase of any of any BSC Offered Securities by the Section 3.06 Accepting
Holders within 90 calendar days after the BSC Offer Expiration Date, subject to Section 3.07, BSC shall have a 120-day period during which to effect a Transfer of any or all of the BSC Offered Securities not elected to be purchased by the Funds
or in respect of which any required consent or regulatory approval shall not have been obtained pursuant to clause (iii) above (collectively, the “BSC Unaccepted Securities”), on substantially the same or more favorable (as to
BSC) terms and conditions as were set forth in the BSC Offer Notice at a price in cash not less than the BSC Offer Price; provided that, if the Transfer is subject to regulatory approval, such 120-day

 
period shall be extended until the expiration of five Business Days after all such approvals shall have been received, but in no event shall such period be extended for more than an additional 90
calendar days. If BSC does not consummate the Transfer of the BSC Unaccepted Securities in accordance with the foregoing time limitations, then the right of BSC to effect the Transfer of such BSC Unaccepted Securities pursuant to this
Section 3.06(d) shall terminate and BSC shall again comply with the procedures set forth in this Section 3.06 and Section 3.07 with respect to any proposed Transfer of Company Securities to any Person. 

(e) The provisions of this Section 3.06 shall not apply to any proposed Transfer of Company Securities by BSC (i) pursuant to a
Public Offering or Rule 144, (ii) to the Company pursuant to a redemption of any Company Securities in accordance with the terms thereof, (iii) to a Permitted Transferee of BSC or (iv) pursuant to Section 3.08. The provisions of
this Section 3.06 shall terminate upon the consummation of an IPO. 
 Section 3.07 Tag-Along Rights. (a) Except as
provided in Section 3.07(e) and subject to Section 3.01, if (i) a Prospective Seller has complied with its obligations under Section 3.05, and is entitled under Section 3.05 to sell any Unaccepted Securities or (ii) BSC
has complied with its obligations under Section 3.06, and is entitled under Section 3.06 to sell any BSC Unaccepted Securities, as the case may be, to any Person (a “Tag-Along Purchaser”), such Prospective Seller (a
“Selling Holder”) shall provide written notice (the “Tag-Along Notice”) of such proposed Transfer (the “Tag-Along Sale”) to each of the Funds and BSC. The Tag-Along Notice shall contain the same
information as an Offer Notice or a BSC Offer Notice, as applicable, and a firm offer by the proposed Tag-Along Purchaser to purchase Company Securities from the Funds and BSC (if applicable) in accordance with this Section 3.07. 

(b) Within 10 Business Days after its receipt of a Tag-Along Notice (the “Tag-Along Notice Period”), each Fund and BSC
(if applicable) shall have the right (each Fund or BSC exercising such right, a “Tag-Along Seller”), exercisable by written notice to the Selling Holder (a “Tag-Along Response Notice”) (specifying the number of
Company Securities which such Tag-Along Seller desires to Transfer, which shall in no event exceed the number of outstanding Common Share Equivalents determined pursuant to this Section 3.07(b) to Transfer to the Tag-Along Purchaser pursuant to
the Tag-Along Sale, Company Securities (regardless of whether such Company Securities constitute part of the class or series of Company Securities proposed to be Transferred by the Selling Holder) representing up to such Tag-Along Seller’s
Tag-Along Portion. Upon the consummation of any Transfer of Company Securities pursuant to a Tag-Along Sale, all of the Tag-Along Sellers participating therein will receive the same form and amount of consideration per Common Share Equivalent
(without regard to class or series) and shall be subject to the same terms and conditions of Transfer as the Prospective Seller sells the Unaccepted Securities. 

(c) Any Tag-Along Response Notice shall be irrevocable and binding, and shall constitute an irrevocable election to participate in the
Tag-Along Sale by each such Tag-Along Seller for the Company Securities specified therein. If at the termination of the Tag-Along Notice Period, any Tag-Along Seller shall not have delivered a Tag-Along Response Notice to the Selling Holder in
accordance with Section 3.07(b), such Tag-Along Seller will be deemed to 

 
have waived any and all of its rights under this Section 3.07 with respect to the Transfer of any of its Company Securities pursuant to such Tag-Along Sale. 

(d) As soon as practicable after the expiration of the Tag-Along Notice Period, the Selling Holder shall notify the Company and the
Tag-Along Sellers of the number of Company Securities the Tag-Along Sellers are obligated to Transfer pursuant to the Tag-Along Sale and Section 3.07(b). Such Stockholder or Stockholders shall notify the Company and the Tag-Along Sellers of the
proposed date of any Transfer (“Transfer Date”) pursuant to this Section 3.07 no less than five Business Days prior to the Transfer Date. No less than two Business Days prior to the Transfer Date, the Tag-Along Sellers shall
deliver to the Selling Holder the certificate or certificates representing the Company Securities to be Transferred pursuant to the Tag-Along Sale by the Tag-Along Sellers (duly endorsed in blank by the Person or Persons in whose name such
certificate is registered or accompanied by a duly executed stock assignment separate from the certificate), together with a limited power-of-attorney authorizing such Selling Holder to Transfer such Company Securities pursuant to the terms of the
Tag-Along Sale and all other documents required to be executed in connection with the Tag-Along Sale. 
 (e) The provisions of this
Section 3.07 shall not apply to any proposed Transfer of Company Securities by any holder (i) pursuant to a Public Offering or Rule 144, (ii) to the Company pursuant to a redemption of any Company Securities in accordance with the
terms thereof, (iii) to a Permitted Transferee of such Stockholder or Stockholders, (iv) pursuant to Section 3.05 (to the extent there are no Unaccepted Securities), (v) pursuant to Section 3.06 (to the extent there are no
BSC Unaccepted Securities) or (vi) Section 3.08. The provisions of this Section 3.07 shall terminate upon the consummation of an IPO. 

Section 3.08 Rights to Drag-Along. (a) Subject to Section 3.08(e), if the holders of at least 60% of the total
number of Common Share Equivalents represented by the aggregate of all Series A Preferred Shares, Series B Preferred Shares, Series C Preferred Shares, Series D Preferred Shares and Series E Preferred Shares, voting together as a class, then
outstanding and the shares of Common Stock issued or then issuable upon the exercise of the BSC Warrant (the “Dragging Holders”) determine to approve any transaction that would constitute a Sale of the Company and/or otherwise
propose to Transfer Shares which, together with the Shares of the other Stockholders required to be Transferred pursuant to this Section 3.08, represent more than 50% of the Common Share Equivalents then outstanding, including the shares of
Common Stock then issuable upon the exercise of the BSC Warrant (the “Drag-Along Offer”), to any Person (the “Drag-Along Purchaser”), such holders shall have the right, exercisable as set forth below, to require
each other Stockholder (each of the foregoing, a “Drag-Along Holder”) to vote its Shares in favor of (or execute any written resolutions with respect to) any such Sale of the Company and/or otherwise Transfer to the Drag-Along
Purchaser the number of its Shares determined pursuant to Section 3.08(d) (without regard to the fact that the Dragging Holders may be proposing to Transfer Shares of a different class or series than those held by the Drag-Along Holders), for
the same consideration per Common Share Equivalent and otherwise on the same terms and conditions upon which the Dragging Holders Transfer their Shares. If the Dragging Holders elect to exercise their right to compel any Drag-Along Holder to
Transfer Shares 

 
pursuant to this Section 3.08 in connection with any Tag-Along Sale, the provisions of this Section 3.08 shall apply in lieu of the provisions of Section 3.07. 

(b) If the Dragging Holders elect to exercise their right to compel a sale pursuant to this Section 3.08 they shall deliver
written notice (a “Drag-Along Notice”) of any Drag-Along Offer to each Drag-Along Holder and the Company, setting forth the consideration per Common Share Equivalent and all other material terms and conditions thereof. Each
Drag-Along Holder shall deliver to the Dragging Holders, prior to the expiration of the 10 Business Day period commencing on the date of the applicable Drag-Along Notice, the certificate or certificates representing the number of Shares required to
be Transferred by such Drag-Along Holder (duly endorsed in blank by the Person or Persons in whose name such certificate is registered or accompanied by a duly executed stock assignment separate from the certificate), together with all other
documents required to be executed by such Drag-Along Holder in connection with such Drag-Along Offer. If any such Drag-Along Holder fails to deliver such certificates to the Dragging Holders, the Company shall cause the books and records of the
Company to show that such Shares are bound by the provisions of this Section 3.08 and that such Shares shall be Transferred only to the Drag-Along Purchaser upon surrender for Transfer by such Drag-Along Holder. 

(c) The Dragging Holders shall have 120 calendar days from the effective date of the Drag-Along Notice to Transfer to the Drag-Along Purchaser
all the Shares subject to the Drag-Along Offer; provided that if such Transfer is subject to regulatory approval, such 120-day period shall be extended until the expiration of five Business Days after all such approvals have been received,
but in no event later than an additional 90 calendar days following the expiration of such 120-day period. Promptly after completion of any Transfer pursuant to this Section 3.08, the Dragging Holders shall notify each Drag-Along Holder of such
completion and shall furnish evidence of such sale (including time of completion) and of the terms and conditions thereof as any Drag-Along Holder may request. The Dragging Holders shall also promptly remit to each Drag-Along Holder the net proceeds
attributable to the Transfer of such Stockholder’s Shares. Notwithstanding the foregoing, each Drag-Along Holder shall be required (i) to bear its proportionate share of any fees, costs, expenses, escrows, holdbacks or adjustments in
purchase price (not to exceed the proceeds attributable to the Transfer of such Drag-Along Holder’s Shares) and (ii) to make such representations, warranties and covenants and enter into such agreements as are customary to be made in such
Drag-Along Holder’s capacity as a stockholder for transactions of the nature of the Drag-Along Offer; provided that the representations and warranties required of each Drag-Along Holder in its capacity as a stockholder shall be limited
to customary representations and warranties with respect to the following matters: existence and power, authorization, non-contravention, and ownership of Shares, and in no event may any Drag-Along Holder be required to assume any indemnity or
similar obligation in an amount in excess of the net proceeds to be received by such Drag-Along Holder in such transaction or to assume any indemnity or similar obligation on a joint and several basis with any Dragging Holders or Drag-Along Holders.
If any Transfer of Shares of a Drag-Along Holder pursuant to this Section 3.08 is not completed prior to the expiration of the applicable period described above, the Dragging Holders may not consummate such Transfer and shall return to each
Drag-Along Holder all certificates representing the Shares which such Stockholder previously 

 
delivered to the Dragging Holders in connection with such Drag-Along Offer, and the right of the Dragging Holders to compel sale pursuant to this Section 3.08 shall terminate and the
Dragging Holders shall again comply with the procedures set forth in this Section 3.08 with respect to any proposed Drag-Along Offer. 

(d) Each Drag-Along Holder may be required to Transfer pursuant to this Section 3.08 Shares representing outstanding Common Share
Equivalents that bear the same proportion to the number of outstanding Common Share Equivalents owned by such Drag-Along Holder as the number of outstanding Common Share Equivalents sold by the Dragging Holders bears to the number of outstanding
Common Share Equivalents owned by the Dragging Holders. 
 (e) The provisions of this Section 3.08 shall not apply to any proposed
Transfer by the Dragging Holders of Shares (i) pursuant to a Public Offering or Rule 144, (ii) to the Company; (iii) to a Permitted Transferee of such Stockholder or (iv) in a transaction that provides for an upfront payment in
an amount less than that would be sufficient to satisfy the Series E and D Liquidation Preference (as defined in Section 4.02(c)(i) of the Certificate of Incorporation), without regard to whether such Series E Preferred Shares or Series D
Preferred Shares have been converted to Common Stock. The provisions of this Section 3.08 shall terminate upon the consummation of an IPO. 

ARTICLE 4 

REGISTRATION RIGHTS 

Section 4.01 Demand Registration. (a) If at any time following the earlier of (x) 180 days after the effective date of
the registration statement for the IPO and (y) the expiration of the period during which the managing underwriters for the IPO shall prohibit the Company from effecting any other public sale or distribution of Company Securities, the Company
shall receive a request from any of the Preferred Stockholders or BSC (the “Requesting Stockholder”) that the Company effect the registration under the Securities Act of all or any portion of such Requesting Stockholder’s
Registrable Securities, which notice shall specify the intended method or methods of disposition thereof, then the Company shall promptly give notice of such requested registration (each such request shall be referred to herein as a “Demand
Registration”) at least 15 Business Days prior to the anticipated filing date of the registration statement relating to such Demand Registration to the other Stockholders and thereupon shall use its reasonable best efforts to effect, as
expeditiously as possible, the registration under the Securities Act of: 
 (i) all Registrable Securities for which the
Requesting Stockholders have requested registration under this Section 4.01, and 
 (ii) subject to the restrictions set
forth in Section 4.01(e) and Section 4.02, all other Registrable Securities of the same class as those requested to be registered by the Requesting Stockholders that any Stockholders with rights to request registration under this
Section 4.01 (all such Stockholders, together with 

 
the Requesting Stockholders, and any Stockholders participating in a Piggyback Registration pursuant to Section 4.02, the “Registering Stockholders”) have requested the Company to
register by request received by the Company within 15 Business Days after such Stockholders receive the Company’s notice of the Demand Registration, 

all to the extent necessary to permit the disposition (in accordance with the intended methods thereof as aforesaid) of the Registrable Securities so to be
registered, provided that, subject to Section 4.01(d), the Company shall not be obligated to effect more than one (1) Demand Registrations for any Preferred Stockholder or BSC, other than Demand Registration to be effected pursuant
to a Registration Statement on Form S-3 (or any successor thereto), for which an unlimited number of Demand Registrations shall be permitted, and provided further that the Company shall not be obligated to effect a Demand Registration unless
the aggregate proceeds expected to be received from the sale of the Registrable Securities requested to be included in such Demand Registration equals or exceeds $40,000,000. In no event shall the Company be required to effect more than one Demand
Registration hereunder within any six-month period. 
 (b) Promptly after the expiration of the 15-Business Day-period referred to in
Section 4.01(a)(ii), the Company will notify all Registering Stockholders of the identities of the other Registering Stockholders and the number of shares of Registrable Securities requested to be included therein. At any time prior to the
effective date of the registration statement relating to such registration, the Requesting Stockholders may revoke such request, without liability to any of the other Registering Stockholders, by providing a notice to the Company revoking such
request. 
 (c) The Company shall be liable for and pay all Registration Expenses in connection with any Demand Registration. 

(d) A Demand Registration shall not be deemed to have occurred: 

(i) unless the registration statement relating thereto (A) has become effective under the Securities Act and (B) has
remained effective for a period of at least 180 calendar days (or such shorter period in which all Registrable Securities of the Registering Stockholders included in such registration have actually been sold thereunder), provided that such
registration statement shall not be considered a Demand Registration if, after such registration statement becomes effective, (1) such registration statement is interfered with by any stop order, injunction or other order or requirement of the
SEC or other governmental agency or court and (2) less than 75% of the Registrable Securities included in such registration statement have been sold thereunder; or 

(ii) if the Maximum Offering Size is reduced in accordance with Section 4.01(e) such that less than 66 2⁄3% of the Registrable Securities of the Requesting Stockholders sought to be included in such registration are included. 

 (e) If a Demand Registration involves an underwritten Public Offering and the managing
underwriter advises the Company and the Requesting Stockholders that, in its view, the number of shares of Registrable Securities requested to be included in such registration (including any securities that the Company proposes to be included that
are not Registrable Securities) exceeds the largest number of shares that can be sold without having an adverse effect on such offering, including the price at which such shares can be sold (the “Maximum Offering Size”), the Company
shall include in such registration, in the priority listed below, up to the Maximum Offering Size: 
 (i) first, all
Registrable Securities requested to be registered by the Preferred Stockholders and BSC (allocated, if necessary for the offering not to exceed the Maximum Offering Size, pro rata among such entities on the basis of the relative number of
Registrable Securities so requested to be included in such registration by each), 
 (ii) second, all Registrable Securities
requested to be included in such registration by any other Registering Stockholder (allocated, if necessary for the offering not to exceed the Maximum Offering Size, pro rata among such other Stockholders on the basis of the relative number of
Registrable Securities so requested to be included in such registration by each such Stockholder), and 
 (iii) third, any
securities proposed to be registered by the Company. 
 Section 4.02 Piggyback Registration. (a) If the Company proposes to
register any Company Securities under the Securities Act (other than a registration on Form S-8, S-4 or F-4, or any successor forms, relating to Common Shares issuable upon exercise of employee stock options or in connection with any employee
benefit or similar plan of the Company or in connection with a direct or indirect acquisition by the Company of another Person), whether or not for sale for its own account, the Company shall each such time give prompt notice at least 30 Business
Days prior to the anticipated filing date of the registration statement relating to such registration to each of the Preferred Stockholders, BSC, the holder of the Pinnacle Preferred Stock Warrants and the Founders, which notice shall set forth such
Stockholder’s rights under this Section 4.02 and shall offer such Stockholder the opportunity to include in such registration statement the number of Registrable Securities of the same class or series as those proposed to be registered as
each such Stockholder may request (a “Piggyback Registration”), subject to the provisions of Section 4.02(b). Upon the request of any such Stockholder made within 15 Business Days after the receipt of notice from the Company
(which request shall specify the number of Registrable Securities intended to be registered by such Stockholder), the Company shall use its best efforts to effect the registration under the Securities Act of all Registrable Securities that the
Company has been so requested to register by all such Stockholders, to the extent requisite to permit the disposition of the Registrable Securities so to be registered, provided that (i) if such registration involves an underwritten
Public Offering, all such Stockholders requesting to be included in the Company’s registration must sell their Registrable Securities to the underwriters selected as provided in Section 4.04(f)(i) on the same terms and conditions as apply
to the Company or the Requesting Stockholders, as applicable and (ii) if, at 

 
any time after giving notice of its intention to register any Company Securities pursuant to this Section 4.02(a) and prior to the effective date of the registration statement filed in
connection with such registration, the Company shall determine for any reason not to register such securities, the Company shall give notice to all such Stockholders and, thereupon, shall be relieved of its obligation to register any Registrable
Securities in connection with such registration. No registration effected under this Section 4.02 shall relieve the Company of its obligations to effect a Demand Registration to the extent required by Section 4.01. The Company shall pay
all Registration Expenses in connection with each Piggyback Registration. 
 (b) If a Piggyback Registration involves an underwritten Public
Offering (other than any Demand Registration, in which case the provisions with respect to priority of inclusion in such offering set forth in Section 4.01(e) shall apply) and the managing underwriter advises the Company that, in its view, the
number of Shares that the Company and such Stockholders intend to include in such registration exceeds the Maximum Offering Size, the Company shall include in such registration, in the following priority, up to the Maximum Offering Size: 

(i) first, so much of the Company Securities proposed to be registered for the account of the Company as would not cause the
offering to exceed the Maximum Offering Size, and 
 (ii) second, all Registrable Securities requested to be included in such
registration by any Stockholders pursuant to Section 4.02 (allocated, if necessary for the offering not to exceed the Maximum Offering Size, pro rata among such Stockholders on the basis of the relative number of shares of Registrable
Securities so requested to be included in such registration by each). 
 Section 4.03 Lock-Up Agreements. If any registration of
Registrable Securities pursuant to this Agreement shall be effected in connection with a Public Offering, neither the Company nor any Stockholder shall effect any public sale or distribution, including any sale pursuant to Rule 144, of any Company
Securities or other security of the Company (except as part of such Public Offering) until the earlier of (i) such time as the Company and the lead managing underwriter shall agree and (ii) 180 calendar days following the date of the final
prospectus relating to such Public Offering (such period, the “Lock-Up Period” for the applicable registration statement); provided that any shares of Common Stock or other securities of the Company acquired by any
Stockholder in such Public Offering or in the open-market transactions of freely tradable shares thereafter shall not be subject to a Lock-Up Period. The Company may impose stop-transfer instructions with respect to securities subject to the
foregoing restriction until the end of the applicable market standoff period. Each Stockholder agrees to execute a market standoff agreement with such underwriters in customary form consistent with the provisions of this Section 4.03. Any
discretionary waiver or termination of the restrictions of any or all of such agreements by the Company or the underwriters shall apply pro rata to all Stockholders subject to such agreements, based on the number of shares subject to such
agreements. 

 Section 4.04 Registration Procedures. Whenever Stockholders request that any
Registrable Securities be registered pursuant to Section 4.01 or Section 4.02, subject to the provisions of such Sections, the Company shall use its reasonable best efforts to effect the registration and the sale of such Registrable
Securities in accordance with the intended method of disposition thereof as quickly as practicable, and, in connection with any such request: 

(a) The Company shall as expeditiously as possible prepare and file with the SEC a registration statement on any form for which the Company
then qualifies or that counsel for the Company shall deem appropriate and which form shall be available for the sale of the Registrable Securities to be registered thereunder in accordance with the intended method of distribution thereof, and use
its best efforts to cause such filed registration statement to become and remain effective for a period of not less than 180 calendar days, or in the case of a shelf registration statement, one year (or such shorter period in which all of the
Registrable Securities of the Stockholders included in such registration statement shall have actually been sold thereunder). 
 (b) Prior
to filing a registration statement or prospectus or any amendment or supplement thereto, the Company shall, if requested, furnish to each participating Stockholder and each underwriter, if any, of the Registrable Securities covered by such
registration statement copies of such registration statement as proposed to be filed, and thereafter the Company shall furnish to such Stockholder and underwriter, if any, such number of copies of such registration statement, each amendment and
supplement thereto (in each case including all exhibits thereto and documents incorporated by reference therein), the prospectus included in such registration statement (including each preliminary prospectus and any summary prospectus) and any other
prospectus filed under Rule 424, Rule 430A, Rule 430B or Rule 430C under the Securities Act and such other documents as such Stockholder or underwriter may reasonably request in order to facilitate the disposition of the Registrable Securities owned
by such Stockholder. 
 (c) After the filing of the registration statement, the Company shall (i) cause the related prospectus to be
supplemented by any required prospectus supplement, and, as so supplemented, to be filed pursuant to Rule 424 under the Securities Act, (ii) comply with the provisions of the Securities Act with respect to the disposition of all Securities
covered by such registration statement during the applicable period in accordance with the intended methods of disposition by the Stockholders thereof set forth in such registration statement or supplement to such prospectus and (iii) promptly
notify each Stockholder holding Registrable Securities covered by such registration statement of any stop order issued or threatened by the SEC or any state securities commission and take all reasonable actions required to prevent the entry of such
stop order or to remove it if entered. 
 (d) The Company shall use its best efforts to (i) register or qualify the Registrable
Securities covered by such registration statement under such other securities or “blue sky” laws of such jurisdictions in the United States as any Registering Stockholder holding such Registrable Securities reasonably (in light of such
Stockholder’s intended plan of distribution) requests and (ii) cause such Registrable Securities to be registered with or approved by such other governmental agencies or authorities as may be necessary by virtue of the business and

 
operations of the Company and do any and all other acts and things that may be reasonably necessary or advisable to enable such Stockholder to consummate the disposition of the Registrable
Securities owned by such Stockholder, provided that the Company shall not be required to (A) qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify but for this Section 4.04(d),
(B) subject itself to taxation in any such jurisdiction or (C) consent to general service of process in any such jurisdiction. 

(e) The Company shall immediately notify each Stockholder holding such Registrable Securities covered by such registration statement, at any
time when a prospectus relating thereto is required to be delivered under the Securities Act, of the occurrence of an event requiring the preparation of a supplement or amendment to such prospectus so that, as thereafter delivered to the purchasers
of such Registrable Securities, such prospectus will not contain an untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading and promptly prepare
and make available to each such Stockholder and file with the SEC any such supplement or amendment. 
 (f) (i) The holders of at least a
majority of the Registrable Securities of the Requesting Stockholders sought to be included in any Demand Registration, shall have the right, to select an underwriter or underwriters in connection with any Public Offering resulting from the exercise
of such Demand Registration, which underwriter or underwriters may include any Affiliate of any Fund, and (ii) the Company shall select an underwriter or underwriters in connection with any other Public Offering. In connection with any Public
Offering, the Company shall enter into customary agreements (including an underwriting agreement in customary form) and take such all other actions as are required in order to expedite or facilitate the disposition of such Registrable Securities in
any such Public Offering, including the engagement of a “qualified independent underwriter” in connection with the qualification of the underwriting arrangements with the FINRA. 

(g) Upon execution of confidentiality agreements in form and substance reasonably satisfactory to the Company, the Company shall make
available for inspection by any Stockholder and any underwriter participating in any disposition pursuant to a registration statement being filed by the Company pursuant to this Section 4.04 and any attorney, accountant or other professional
retained by any such Stockholder or underwriter (collectively, the “Inspectors”), all financial and other records, pertinent corporate documents and properties of the Company (collectively, the “Records”) as shall
be reasonably necessary or desirable to enable them to exercise their due diligence responsibility, and cause the Company’s officers, directors and employees to supply all information reasonably requested by any Inspectors in connection with
such registration statement. Records that the Company determines, in good faith, to be confidential and that it notifies the Inspectors are confidential shall not be disclosed by the Inspectors unless (i) the disclosure of such Records is
necessary to avoid or correct a misstatement or omission in such registration statement or (ii) the release of such Records is ordered pursuant to a subpoena or other order from a court of competent jurisdiction. Each Stockholder agrees that
information obtained by it as a result of such inspections shall be deemed confidential and shall not be used by it or its Affiliates as the basis for any market transactions in the Company Securities unless and until such information is made
generally available to the 

 
public. Each Stockholder further agrees that, upon learning that disclosure of such Records is sought in a court of competent jurisdiction, it shall give notice to the Company and allow the
Company, at its expense, to undertake appropriate action to prevent disclosure of the Records deemed confidential. 
 (h) The Company shall
furnish to each Registering Stockholder and to each such underwriter, if any, a signed counterpart, addressed to such Stockholder or underwriter, of (i) an opinion or opinions of counsel to the Company and (ii) a comfort letter or comfort
letters from the Company’s independent public accountants, each in customary form and covering such matters of the kind customarily covered by opinions or comfort letters, as the case may be, as a majority of such Stockholders or the managing
underwriter therefor reasonably requests. 
 (i) The Company shall otherwise use its best efforts to comply with all applicable rules and
regulations of the SEC, and make available to its security Stockholders, as soon as reasonably practicable, an earnings statement or such other document that shall satisfy the requirements of Rule 158 under the Securities Act. 

(j) The Company may require each Stockholder promptly to furnish in writing to the Company such information regarding the distribution of the
Registrable Securities as the Company may from time to time request and such other information as may be legally required in connection with such registration. 

(k) Each Stockholder agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in
Section 4.04(e), such Stockholder shall forthwith discontinue disposition of Registrable Securities pursuant to the registration statement covering such Registrable Securities until such Stockholder’s receipt of the copies of the
supplemented or amended prospectus contemplated by Section 4.04(e), and, if so directed by the Company, such Stockholder shall deliver to the Company all copies, other than any permanent file copies then in such Stockholder’s possession,
of the most recent prospectus covering such Registrable Securities at the time of receipt of such notice. If the Company shall give such notice, the Company shall extend the period during which such registration statement shall be maintained
effective (including the period referred to in Section 4.04(a) by the number of days during the period from and including the date of the giving of notice pursuant to Section 4.04(e) to the date when the Company shall make available to
such Stockholder a prospectus supplemented or amended to conform with the requirements of Section 4.04(e). 
 (l) The Company shall use
its best efforts to list all Registrable Securities covered by such registration statement on any securities exchange or quotation system on which any of the Registrable Securities are then listed or traded. 

(m) The Company shall have appropriate officers of the Company (i) prepare and make presentations at any “road shows” and
before analysts and rating agencies, as the case may be, (ii) take other actions to obtain ratings for any Registrable Securities and (iii) otherwise use their best efforts to cooperate as reasonably requested by the underwriters in the
offering, marketing or selling of the Registrable Securities. 

 Section 4.05 Indemnification by the Company. The Company agrees to indemnify and hold
harmless each Stockholder beneficially owning any Registrable Securities covered by a registration statement, its officers, directors, employees, partners and agents, and each Person, if any, who controls such Stockholder within the meaning of
Section 15 of the Securities Act or Section 20 of the Exchange Act from and against any and all losses, claims, damages, liabilities and expenses (including reasonable expenses of investigation and reasonable attorneys’ fees and
expenses) (“Damages”) caused by or relating to any untrue statement or alleged untrue statement of a material fact contained in any registration statement or prospectus relating to the Registrable Securities (as amended or
supplemented if the Company shall have furnished any amendments or supplements thereto) or any preliminary prospectus, or caused by or relating to any omission or alleged omission to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading, except insofar as such Damages are caused by or related to any such untrue statement or omission or alleged untrue statement or omission so made based upon information furnished in writing to
the Company by such Stockholder or on such Stockholder’s behalf expressly for use therein. The Company also agrees to indemnify any underwriters of the Registrable Securities, their officers and directors and each Person who controls such
underwriters within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act on substantially the same basis as that of the indemnification of the Stockholders provided in this Section 4.05. 

Section 4.06 Indemnification by Participating Stockholders. Each Stockholder holding Registrable Securities included in any
registration statement agrees, severally but not jointly, to indemnify and hold harmless the Company, its officers, directors and agents and each Person, if any, who controls the Company within the meaning of either Section 15 of the Securities
Act or Section 20 of the Exchange Act to the same extent as the foregoing indemnity from the Company to such Stockholder, but only with respect to information furnished in writing by such Stockholder or on such Stockholder’s behalf
expressly for use in any registration statement or prospectus relating to the Registrable Securities, or any amendment or supplement thereto, or any preliminary prospectus. Each such Stockholder also agrees to indemnify and hold harmless
underwriters of the Registrable Securities, their officers and directors and each Person who controls such underwriters within the meaning of either Section 15 of the Securities Act or Section 20 of the Exchange Act on substantially the
same basis as that of the indemnification of the Company provided in this Section 4.06. As a condition to including Registrable Securities in any registration statement filed in accordance with ARTICLE 4, the Company may require that it shall
have received an undertaking reasonably satisfactory to it from any underwriter to indemnify and hold it harmless to the extent customarily provided by underwriters with respect to similar securities. No Stockholder shall be liable under this
Section 4.06 for any Damages in excess of the net proceeds realized by such Stockholder in the sale of Registrable Securities of such Stockholder to which such Damages relate. 

Section 4.07 Conduct of Indemnification Proceedings. If any proceeding (including any governmental investigation) shall be
instituted involving any Person in respect of which indemnity may be sought pursuant to this ARTICLE 4, such Person (an “Indemnified Party”) shall promptly notify the Person against whom such indemnity may be sought
(the “Indemnifying Party”) in writing and the Indemnifying Party shall assume the defense thereof,  

 
including the employment of counsel reasonably satisfactory to such Indemnified Party, and shall assume the payment of all fees and expenses, provided that the failure of any
Indemnified Party so to notify the Indemnifying Party shall not relieve the Indemnifying Party of its obligations hereunder except to the extent that the Indemnifying Party is materially prejudiced by such failure to notify. In any such proceeding,
any Indemnified Party shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party unless (i) the Indemnifying Party and the Indemnified Party shall have mutually
agreed to the retention of such counsel or (ii) in the reasonable judgment of such Indemnified Party representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. It is
understood that, in connection with any proceeding or related proceedings in the same jurisdiction, the Indemnifying Party shall not be liable for the reasonable fees and expenses of more than one separate firm of attorneys (in addition to any local
counsel) at any time for all such Indemnified Parties, and that all such fees and expenses shall be reimbursed as they are incurred. In the case of any such separate firm for the Indemnified Parties, such firm shall be designated in writing by the
Indemnified Parties. The Indemnifying Party shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent, or if there be a final judgment for the plaintiff, the Indemnifying Party
shall indemnify and hold harmless such Indemnified Parties from and against any loss or liability (to the extent stated above) by reason of such settlement or judgment. Without the prior written consent of the Indemnified Party, no Indemnifying
Party shall effect any settlement of any pending or threatened proceeding in respect of which any Indemnified Party is or could have been a party and indemnity could have been sought hereunder by such Indemnified Party, unless such settlement
includes an unconditional release of such Indemnified Party from all liability arising out of such proceeding. 
 Section 4.08
Contribution. If the indemnification provided for in this ARTICLE 4 is unavailable to the Indemnified Parties in respect of any Damages, then each such Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to
the amount paid or payable by such Indemnified Party as a result of such Damages (i) as between the Company and the Stockholders holding Registrable Securities covered by a registration statement on the one hand and the underwriters on the
other, in such proportion as is appropriate to reflect the relative benefits received by the Company and such Stockholders on the one hand and the underwriters on the other, from the offering of the Registrable Securities, or if such allocation is
not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits but also the relative fault of the Company and such Stockholders on the one hand and of such underwriters on the other in connection with
the statements or omissions that resulted in such Damages, as well as any other relevant equitable considerations and (ii) as between the Company on the one hand and each such Stockholder on the other, in such proportion as is appropriate to
reflect the relative fault of the Company and of each such Stockholder in connection with such statements or omissions, as well as any other relevant equitable considerations. The relative benefits received by the Company and such Stockholders on
the one hand and such underwriters on the other shall be deemed to be in the same proportion as the total proceeds from the offering (net of underwriting discounts and commissions but before deducting expenses) received by the Company and such
Stockholders bear to the total underwriting discounts and commissions 

 
received by such underwriters, in each case as set forth in the table on the cover page of the prospectus. The relative fault of the Company and such Stockholders on the one hand and of such
underwriters on the other shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the
Company and such Stockholders or by such underwriters. The relative fault of the Company on the one hand and of each such Stockholder on the other shall be determined by reference to, among other things, whether the untrue or alleged untrue
statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by such party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent
such statement or omission. 
 The Company and the Stockholders agree that it would not be just and equitable if contribution pursuant to
this Section 4.08 were determined by pro rata allocation (even if the underwriters were treated as one entity for such purpose) or by any other method of allocation that does not take account of the equitable considerations referred to in the
immediately preceding paragraph. The amount paid or payable by an Indemnified Party as a result of the Damages referred to in the immediately preceding paragraph shall be deemed to include, subject to the limitations set forth above, any legal or
other expenses reasonably incurred by such Indemnified Party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this Section 4.08, no underwriter shall be required to contribute any amount
in excess of the amount by which the total price at which the Registrable Securities underwritten by it and distributed to the public were offered to the public exceeds the amount of any Damages that such underwriter has otherwise been required to
pay by reason of such untrue or alleged untrue statement or omission or alleged omission, and no Stockholder shall be required to contribute any amount in excess of the amount by which the total price at which the Registrable Securities of such
Stockholder were offered to the public (less underwriters’ discounts and commissions) exceeds the amount of any Damages that such Stockholder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or
alleged omission. No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. Each
Stockholder’s obligation to contribute pursuant to this Section 4.08 is several in the proportion that the proceeds of the offering received by such Stockholder bears to the total proceeds of the offering received by all such Stockholders
and not joint. 
 Section 4.09 Participation in Public Offering. No Stockholder may participate in any Public Offering hereunder
unless such Stockholder (a) agrees to sell such Stockholder’s Registrable Securities on the basis provided in any underwriting arrangements approved by the Persons entitled hereunder to approve such arrangements and (b) completes and
executes all questionnaires, powers of attorney, indemnities, underwriting agreements and other documents reasonably required under the terms of such underwriting arrangements and the provisions of this Agreement in respect of registration rights.

 Section 4.10 Other Indemnification. Indemnification similar to that specified herein
(with appropriate modifications) shall be given by the Company and each Stockholder participating therein with respect to any required registration or other qualification of securities under any federal or state law or regulation or governmental
authority other than the Securities Act. 
 Section 4.11 Cooperation by the Company. If any Stockholder shall transfer any
Registrable Securities pursuant to Rule 144, the Company shall cooperate, to the extent commercially reasonable, with such Stockholder and shall provide to such Stockholder such information as such Stockholder shall reasonably request. 

Section 4.12 No Transfer of Registration Rights. None of the rights of Stockholders under this ARTICLE 4 shall be assignable by
any Stockholder to any Person acquiring Securities in any Public Offering or pursuant to Rule 144. 
 Section 4.13 Termination of
Registration Rights. The right of any Stockholder to request registration or inclusion of Registrable Securities in any registration pursuant to this ARTICLE 4 shall terminate upon the earlier of: (i) the date five (5) years following
an IPO, or (ii) such time as such Stockholder holds less than 1% of the Company’s Common Share Equivalents, the Company has completed its IPO, and all Registrable Securities of the Company issuable or issued upon conversion of the Company
Securities held by and issuable to such Stockholder (and its Affiliates) may be sold pursuant to Rule 144 during any 90 day period. 

ARTICLE 5 

CERTAIN COVENANTS 

Section 5.01 Confidentiality. (a) Each Stockholder (other than BSC which shall be subject to the Confidentiality
Agreement) agrees that Confidential Information furnished and to be furnished to it has been and may in the future be made available in connection with such Stockholder’s investment in the Company. Each such Stockholder agrees that it shall
use, and that it shall cause any Person to whom Confidential Information is disclosed pursuant to clause (i) below to use, the Confidential Information only in connection with its investment in the Company and not for any other purpose
(including to disadvantage competitively the Company, any of its Affiliates or any other Stockholder). Each such Stockholder further acknowledges and agrees that it shall not disclose any Confidential Information to any Person, except that
Confidential Information may be disclosed: 
 (i) to such Stockholder’s Representatives in the normal course of the
performance of their duties or to any financial institution providing credit to such Stockholder; 
 (ii) to the extent
required by applicable law, rule or regulation (including complying with any oral or written questions, interrogatories, requests for information or documents, subpoena, civil investigative demand or similar

 
process to which a Stockholder is subject, provided that such Stockholder agrees to give the Company prompt notice of such request(s), to the extent practicable, so that the Company may
seek an appropriate protective order or similar relief (and the Stockholder shall cooperate with such efforts by the Company, and shall in any event make only the minimum disclosure required by such law, rule or regulation)); 

(iii) to any Person to whom such Stockholder is contemplating a Transfer of its Company Securities, provided that such
Transfer would not be in violation of the provisions of this Agreement and such potential transferee is advised of the confidential nature of such information and agrees to be bound by a confidentiality agreement consistent with the provisions
hereof; 
 (iv) to the extent related to the tax treatment and tax structure of the transactions contemplated by this
Agreement (including all materials of any kind, such as opinions or other tax analyses that the Company, its Affiliates or its Representatives have provided to such Stockholder relating to such tax treatment and tax structure), provided that
the foregoing does not constitute an authorization to disclose the identity of any existing or future party to the transactions contemplated by this Agreement or their Affiliates or Representatives, or, except to the extent relating to such tax
structure or tax treatment, any specific pricing terms or commercial or financial information; or 
 (v) if the prior written
consent of the Board shall have been obtained. 
 Nothing contained herein shall prevent the use (subject, to the extent possible, to a protective order) of
Confidential Information in connection with the assertion or defense of any claim by or against the Company or any Stockholder. 

(b) “Confidential Information” means any information furnished or made available to any Stockholder (other than BSC)
pursuant to Section 5.02 or Section 5.03 or otherwise solely in such Stockholder’s capacity as a holder of Company Securities, including pursuant to Section 2.1(b) of the BSC Warrant, concerning the Company or any Persons that
are or become its Subsidiaries or the financial condition, business, operations or prospects of the Company or any such Persons in the possession of or furnished to any Stockholder (including by virtue of its present or former right to designate a
director of the Company), provided that the term “Confidential Information” does not include information that (i) is or becomes generally available to the public other than as a result of a disclosure by a
Stockholder or its directors, officers, employees, stockholders, members, partners, agents, counsel, investment advisers or other representatives (all such persons being collectively referred to as “Representatives”) in violation of
the Stock Purchase Agreement among the Company, BSC and Boston Scientific Corporation, dated as of March 28, 2008, or this Agreement, (ii) was available to such Stockholder on a non-confidential basis prior to its disclosure to such
Stockholder or its Representatives by the Company, (iii) becomes available to such Stockholder on a non-confidential basis from a source other than the Company after the disclosure of such information 

 
to such Stockholder or its Representatives by the Company, which source is (at the time of receipt of the relevant information) not, to the best of such Stockholder’s knowledge, bound by a
confidentiality agreement with (or other confidentiality obligation to) the Company or another Person or (iv) is independently developed by such Stockholder without violating any confidentiality agreement with, or other obligation of secrecy
to, the Company. 
 (c) For purposes of clarification, the inapplicability of the provisions of this Section 5.01 as to BSC shall not
in any way affect the obligations of BSC under the terms of the Confidentiality Agreement. 
 Section 5.02 Financial Statements and
Other Information. (a) The Company shall cause to be prepared and delivered to each Qualified Holder all the information described in this Section 5.02(a): 

(i) as soon as practicable and, in any event within 20 calendar days after the end of each month, the unaudited consolidated
balance sheet of the Company and its Subsidiaries as at the end of such month and the related unaudited statement of operations and cash flow for such month, and for the portion of the fiscal year then ended, in each case prepared in accordance with
GAAP, setting forth in comparative form the figures for the corresponding month and portion of the previous fiscal year, and the figures for the corresponding month and portion of the then current fiscal year as in the Company’s annual
operating budget; 
 (ii) as soon as practicable and, in any event, within 45 days after the end of each of the first three
fiscal quarters, the unaudited consolidated balance sheet of the Company and its Subsidiaries as at the end of such quarter and the related unaudited statement of operations and cash flow for such quarter and for the portion of the fiscal year then
ended, in each case prepared in accordance with GAAP, and the capitalization table of the Company as of the end of such fiscal quarter; 

(iii) as soon as practicable and, in any event, within 180 calendar days after the end of each fiscal year, (A) the
audited consolidated balance sheet of the Company and its Subsidiaries as at the end of such fiscal year and the related audited statement of operations and cash flow for such fiscal year, and for the portion of the fiscal year then ended, in each
case prepared in accordance with GAAP and certified by a firm of independent public accountants of nationally recognized standing, together with a comparison of the figures in such financial statements with the figures for the previous fiscal year
and the figures in the Company’s annual operating budget, (B) any management letters or other correspondence from such accountants, (C) the Company’s annual operating budget for the coming fiscal year and (D) the
capitalization table of the Company as of the end of such fiscal year; 

 (iv) promptly following the preparation thereof, a copy of any revisions to the
annual operating budget delivered pursuant to clause (C) above; 
 (v) promptly upon their becoming available, copies of
(A) all financial statements, reports, notices and proxy statements sent or made generally available by the Company to any of its security holders, (B) all regular and periodic reports and all registration statements and prospectuses filed
by the Company with any securities exchange or with the SEC and (c) all press releases and other statements made generally available by the Company to the public; 

(vi) as soon as practicable and, in any event, within five Business Days after any officer of the Company obtains knowledge
thereof, notice (with a description in reasonable detail, and stating the action that the Company is taking or proposes to take with respect thereto) of (A) the commencement of any material litigation, investigation or other proceeding to which
the Company or any of its Subsidiaries is a party before any court or arbitrator or any governmental body, agency or official or (B) the existence of any material default or breach under this Agreement or any other material contract or
agreement to which the Company or any of its Subsidiaries is a party; and 
 (vii) as promptly as reasonably practicable,
such other information with respect to the Company or any of its Subsidiaries as may determined by the Board of Directors. 
 (b) Any
information provided to a Qualified Holder (other than BSC) pursuant to this Section 5.02 is “Confidential Information” subject to the provisions of Section 5.01(a) and, following an IPO, in addition to the provisions of
Section 5.01(a), shall be kept confidential by such Qualified Holder to the extent necessary to ensure compliance with the Commission’s Regulation FD without a broad public dissemination of such information. 

(c) For purposes of clarification, the inapplicability of the provisions of Section 5.02(b) above as to BSC shall not in any way affect
the obligations of BSC under the terms of the Confidentiality Agreement. 
 Section 5.03 Inspection of Property. To the extent
not otherwise prohibited by law or regulation, and subject to any reasonable limitations imposed by the Company with respect to competitively sensitive information, the Company shall permit any representatives designated by any Qualified Holder,
upon reasonable notice and during normal business hours and at such other times as any such Qualified Holder may reasonably request, to (i) visit and inspect any of the properties of the Company and its Subsidiaries, (ii) examine the
corporate and financial records of the Company and its Subsidiaries and make copies thereof or extracts therefrom and (iii) discuss the affairs, finances and accounts of any such entities with the directors, officers, key employees and
independent accountants of the Company and its Subsidiaries. 

 Section 5.04 Limitations on Subsequent Registration Rights. The Company agrees that
it shall not enter into any agreement with any holder or prospective holder of any securities of the Company (other than with Pinnacle Ventures II Equity Holdings, L.L.C. and Pinnacle Ventures III Equity Holdings, L.L.C. or affiliates thereof in
connection with the Pinnacle Preferred Stock Warrants) (a) that would allow such holder or prospective holder to include such securities in any Demand Registration or Piggyback Registration unless, under the terms of such agreement, such holder
or prospective holder may include such securities in any such registration only to the extent that their inclusion would not reduce the amount of the Registrable Securities of the Stockholders included therein or (b) on terms otherwise more
favorable than this Agreement. 
 Section 5.05 Conflicting Agreements. The Company and each Stockholder represents and agrees
that it shall not (a) grant any proxy or enter into or agree to be bound by any voting trust or agreement with respect to the Company Securities, except as expressly contemplated by this Agreement, (b) enter into any agreement or
arrangement of any kind with any Person with respect to any Company Securities inconsistent with the provisions of this Agreement or for the purpose or with the effect of denying or reducing the rights of any other Stockholder under this Agreement,
including agreements or arrangements with respect to the Transfer or voting of its Company Securities or (c) act, for any reason, as a member of a group or in concert with any other Person in connection with the Transfer or voting of its
Company Securities in any manner that is inconsistent with the provisions of this Agreement. 
 Section 5.06 Proprietary Information
and Inventions Agreement. The Company shall require all employees and consultants to execute and deliver a Proprietary Information and Inventions Agreement substantially in a form approved by the Company’s counsel or Board of Directors.

 Section 5.07 Director and Officer Insurance. The Company will use its best efforts to obtain and maintain in full force and
effect director and officer liability insurance in an amount satisfactory to the Board. 
 Section 5.08 Reservation of Common
Stock. The Company will at all times reserve and keep available, solely for issuance and delivery upon the conversion of any outstanding shares of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D
Preferred Stock and Series E Preferred Stock and the exercise of the BSC Warrant, the Pinnacle Warrants and the Series D Warrants, all Common Stock issuable from time to time upon such conversion or exercise. 

Section 5.09 Stock Vesting. Unless otherwise approved by the Board of Directors, all Options and other Common Share Equivalents
issued after the date of this Agreement to employees, directors, consultants and other service providers shall be subject to vesting as follows: (a) twenty-five percent (25%) of such stock shall vest at the end of the first year following
the earlier of the date of issuance or such person’s services commencement date with the company; and (b) seventy-five percent (75%) of such stock shall vest ratably over the remaining three (3) years. 

 Section 5.10 Termination. All covenants of the Company contained in ARTICLE 5
(other than the provisions of Section 5.01, which shall expire pursuant to its own terms) shall expire and terminate as to each Stockholder upon the earlier of (i) the consummation of an IPO or (ii) upon a Sale of the Company. 

ARTICLE 6 

MISCELLANEOUS 

Section 6.01 Binding Effect; Assignability; Benefit. (a) This Agreement shall inure to the benefit of and be binding upon the
parties hereto and their respective heirs, successors, legal representatives and permitted assigns. Any Stockholder that ceases to own beneficially any Company Securities shall cease to be bound by the terms hereof (other than (i) the
provisions of Section 4.05, Section 4.06, Section 4.07, Section 4.08 and Section 4.10 applicable to such Stockholder with respect to any offering of Registrable Securities completed before the date such Stockholder ceased to
own any Company Securities and (ii) Section 5.01, Section 6.02, Section 6.05, Section 6.06, Section 6.07 and Section 6.08). 

(b) Neither this Agreement nor any right, remedy, obligation or liability arising hereunder or by reason hereof shall be assignable by any
party hereto pursuant to any Transfer of Company Securities or otherwise, except that any Person acquiring Company Securities from any Stockholder in a Transfer in compliance with ARTICLE 3 (but excluding any such Transfer made in a Public Offering,
through a national securities exchange, pursuant to Rule 144 following an IPO or pursuant to a Distribution in Kind in connection with which the Fund effecting such Distribution in Kind determines not to require the distributees to have agreed in
writing to be bound by the terms of this Agreement or to be entitled to the benefit hereof) shall (unless already bound hereby) execute and deliver to the Company an agreement to be bound by this Agreement in the form of Exhibit D hereto and
shall thenceforth be a “Stockholder.” 
 (c) Nothing in this Agreement, expressed or implied, is intended to confer on any Person
other than the parties hereto, and their respective heirs, successors, legal representatives and permitted assigns, any rights, remedies, obligations or liabilities under or by reason of this Agreement. 

Section 6.02 Notices. All notices, requests and other communications to any party hereunder shall be in writing (including by
electronic mail and facsimile transmission) and shall be deemed to have been duly given or made if sent by electronic mail and facsimile transmission (with confirmation in writing), delivered personally or sent by registered or certified mail
(postage prepaid, return receipt requested) to such party at its address (including electronic mail address) or facsimile number set forth in the signature pages hereto, or such other address (including electronic mail address) or facsimile number
as such party may hereinafter specify for the purpose to the party giving such notice. All notices, requests and other communications shall be deemed received on the date of receipt by the recipient thereof if received prior to 5:00 p.m. in the
place of receipt and such day is a Business Day in the place of receipt. Otherwise, any such notice, request or communication shall be deemed not to have been received until the next 

 
succeeding Business Day in the place of receipt. Any Person that becomes a Stockholder shall provide its address (including electronic mail address) and facsimile number to the Company, which
shall promptly provide such information to each other Stockholder. 
 Section 6.03 Waiver; Amendment; Termination. (a) No
provision of this Agreement may be amended, waived or otherwise modified (either generally or in a particular instance, and either retroactively or prospectively) except by an instrument in writing executed by the Company with approval of the Board
of Directors and Stockholders holding at least 60% of the outstanding Common Share Equivalents held by Stockholders at the time of such proposed amendment or modification; provided that any amendment that would disproportionately impose
restrictions in addition to the transfer restrictions set forth in ARTICLE 3 on a dissenting Stockholder’s right to transfer its Shares, shall require the consent of the Stockholder so affected; provided further that any amendment of
Section 2.01(a)(i) and Section 2.01(a)(ii) may not be effected without, and shall require, the consent of each Fund whose rights pursuant to such Section 2.01(a)(i) and Section 2.01(a)(ii) are affected by such amendment;
provided further that any amendment of Section 3.06 (and the definitions referenced or used therein) may not be effected without, and shall require, the consent of BSC; provided further that any Investors purchasing shares under
the Series E Purchase Agreement after the Initial Closing (as defined in the Series E Purchase Agreement) may become parties to this Agreement as a “Preferred Stockholder” without any amendment of this Agreement pursuant to this paragraph
or any consent or approval of any other Stockholder; provided further that any amendment of the definition of “Qualified Holder” that adversely affects the rights of a holder of Series D Preferred Shares to be treated as a Qualified
Holder under this Agreement, if such holder of Series D Preferred Shares was a Qualified Holder after the Initial First Tranche Closing of the Series D Financing, shall not be effective against such holder of Series D Preferred Shares without the
written consent thereto of the holders of at least 80% of the then outstanding Series D Preferred Shares; provided further that any amendment of Section 5.02 (or any of the definitions referenced or used therein) that adversely affects
the rights of a holder of Series D Preferred Shares under such Section shall not be effective against such holder of Series D Preferred Shares without the written consent thereto of the holders of at least 80% of the then outstanding Series D
Preferred Shares; and provided further that any amendment to Section 4.03 relating to exclusions of securities purchased in the open-market transactions or pursuant to a Public Offering from the Lock-Up Period that adversely affects the
rights of Deerfield may not be effected without, and shall require, the consent of Deerfield. Any such amendment, waiver, discharge or termination effected in accordance with this paragraph shall be binding upon each Stockholder that has entered
into this Agreement. Except as otherwise provided in the first sentence of this Section 6.03(a), each Stockholder acknowledges that by the operation of this paragraph, the holders of at least 60% of the outstanding Common Share Equivalents held
by Stockholders at the time of such proposed amendment or modification will have the right and power to modify, diminish or eliminate all rights of such Stockholder under this Agreement. 

(b) In addition, any amendment or modification of any provision of this Agreement that would disparately and adversely affect any Fund in a
manner disproportionate to the manner in which the other Funds are affected by such amendment or modification may be effected only with the consent of such disparately and adversely affected Fund. 

 (c) This Agreement shall terminate as to all provisions hereunder and be of no further force or
effect upon the date five (5) years following the Closing of a Qualifying IPO. 
 Section 6.04 Fees and Expenses. Except as
provided in the Series E Purchase Agreement or in this Agreement, all costs and expenses incurred in connection with the transactions contemplated by this Agreement shall be paid by the party incurring such costs or expenses. 

Section 6.05 Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of
Delaware, and all rights and remedies shall be governed by said laws, without regard to conflict of laws principles of such State. 

Section 6.06 Jurisdiction. To the fullest extent permitted by law, the parties hereto agree that any claim, suit, action or
proceeding seeking to enforce any provision of, or based on any matter arising out of or in connection with, this Agreement or the other agreements or transactions contemplated hereby shall only be brought in the Chancery Court of the State of
Delaware (or other appropriate state court in the State of Delaware) or the Federal courts located in the State of Delaware and not in any other State or Federal courts located in the United States of America or any court in any other country, and
each of the parties hereby consents to the jurisdiction of such courts (and of the appropriate appellate courts therefrom) in any such suit, action or proceeding and irrevocably waives, to the fullest extent permitted by law, any objection which it
may now or hereafter have to the laying of the venue of any such suit, action or proceeding in any such court or that any such suit, action or proceeding which is brought in any such court has been brought in an inconvenient forum. To the fullest
extent permitted by law, process in any such suit, action or proceeding may be served on any party anywhere in the world, whether within or without the jurisdiction of any such court. Without limiting the foregoing, each party agrees, to the fullest
extent permitted by law, that service of process on such party as provided in 6.02 shall be deemed effective service of process on such party. 

Section 6.07 WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY
LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. 
 Section 6.08 Specific
Enforcement. Each party hereto acknowledges that the remedies at law of the other parties for a breach or threatened breach of this Agreement would be inadequate and, in recognition of this fact, any party to this Agreement, without posting any
bond, and in addition to all other remedies that may be available, shall be entitled to obtain equitable relief in the form of specific performance, a temporary restraining order, a temporary or permanent injunction or any other equitable remedy
that may then be available. 
 Section 6.09 Counterparts; Effectiveness. This Agreement may be executed in any number of
counterparts, each of which shall be deemed to be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. This Agreement shall become effective when each party hereto shall have received counterparts
hereof signed by all of 

 
the other parties hereto. Until and unless each party has received a counterpart hereof signed by the other party hereto, this Agreement shall have no effect and no party shall have any right or
obligation hereunder (whether by virtue of any other oral or written agreement or other communication). 
 Section 6.10 Entire
Agreement. This Agreement constitutes the entire agreement among the parties hereto and supersede all prior and contemporaneous agreements and understandings, both oral and written, among the parties hereto with respect to the subject matter
hereof and thereof. 
 Section 6.11 Aggregation Of Stock. All Shares held or acquired by Affiliates of any Stockholder shall be
aggregated together for the purpose of determining the availability of any rights of such Stockholder under this Agreement. 

Section 6.12 Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent
jurisdiction or other authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Agreement shall remain in full force and effect and shall in no way be affected, impaired or invalidated
so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party. Upon such a determination, the parties shall negotiate in good faith to modify this Agreement so as to
effect the original intent of the parties as closely as possible in an acceptable manner so that the transactions contemplated hereby be consummated as originally contemplated to the fullest extent possible. 

Section 6.13 Not a Voting Trust. This Agreement is not a voting trust governed by Section 218 of the Delaware General
Corporation Law or Section 706(b) of the California Corporations Code and should not be interpreted as such. 
 [The remainder of
this page is left intentionally blank.] 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their
respective authorized officers as of the day and year first above written. 
  

					
	TV2 HOLDING COMPANY
		
	By:	 	 /s/ Michael Kramer

		 	Name:	 	Michael Kramer
		 	Title:	 	Chief Financial Officer
		 	Address:	 	3910 Brickway Boulevard, Santa Rosa, California 95403
			
		 	Facsimile:	 	
		 	E-mail:	 	

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their
respective authorized officers as of the day and year first above written. 
  

									
	STOCKHOLDERS:
	
	DEERFIELD SPECIAL SITUATIONS FUND, L.P.
	By:	 	Deerfield Mgmt, L.P.
		 	General Partner
		 	By:	 	J.E. Flynn Capital, LLC
		 		 	General Partner
				
		 		 	By:	 	 /s/ David J. Clark

		 		 		 	Name:	 	David J. Clark
		 		 		 	Title:	 	Authorized Signatory
	
	DEERFIELD SPECIAL SITUATIONS INTERNATIONAL MASTER FUND, L.P.
	By:	 	Deerfield Mgmt, L.P.
		 	General Partner
		 	By:	 	J.E. Flynn Capital, LLC
		 		 	General Partner
				
		 		 	By:	 	 /s/ David J. Clark

		 		 		 	Name:	 	David J. Clark
		 		 		 	Title:	 	Authorized Signatory
	
	DEERFIELD PRIVATE DESIGN FUND II, L.P.
	By:	 	Deerfield Mgmt, L.P.
		 	General Partner
		 	By:	 	J.E. Flynn Capital, LLC
		 		 	General Partner
				
		 		 	By:	 	 /s/ David J. Clark

		 		 		 	Name:	 	David J. Clark
		 		 		 	Title:	 	Authorized Signatory

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their
respective authorized officers as of the day and year first above written. 
  

									
	STOCKHOLDERS:
	
	DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P.
	By:	 	Deerfield Mgmt, L.P.
		 	General Partner
		 	By:	 	J.E. Flynn Capital, LLC
		 		 	General Partner
				
		 		 	By:	 	 /s/ David J. Clark

		 		 		 	Name:	 	David J. Clark
		 		 		 	Title:	 	Authorized Signatory

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their
respective authorized officers as of the day and year first above written. 
  

			
	STOCKHOLDERS:
	
	KAISER PERMANENTE VENTURES LLC- SERIES A
		
	By:	 	 /s/ Thomas Meier

	Name:	 	 Thomas Meier

	Title:	 	 SVP & Treasurer

	Attn:	 	Chris Grant - KP Ventures
	One Kaiser Plaza, 22nd Floor
	Oakland, CA 94612
	
	KAISER PERMANENTE VENTURES LLC – SERIES B
		
	By:	 	 /s/ Thomas Meier

	Name:	 	 Thomas Meier

	Title:	 	 Management Committee

	Attn:	 	Chris Grant - KP Ventures
	One Kaiser Plaza, 22nd Floor
	Oakland, CA 94612
	
	THE PERMANENTE FEDERATION LLC – SERIES J
		
	By:	 	 /s/ Ilene Moore

	Name:	 	 Ilene Moore

	Title:	 	 General Counsel

	Attn:	 	Chris Grant - KP Ventures
	One Kaiser Plaza, 22nd Floor
	Oakland, CA 94612

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their
respective authorized officers as of the day and year first above written. 
  

			
	STOCKHOLDERS:
	
	REDMILE CAPITAL FUND, LP
	By:	 	Redmile Group (GP), LLC
	Its:	 	General Partner
	By:	 	Redmile Group, LLC
	Its:	 	Investment Manager
		
	By:	 	 /s/Jeremy Green

	Name:	 	Jeremy Green
	Title:	 	Managing Member of the Investment Manager and the General Partner
	100 Pine Street, Suite 1925
	San Francisco, CA 94111
	
	REDMILE CAPITAL OFFSHORE FUND, LTD.
	By:	 	Redmile Group, LLC
	Its:	 	Investment Manager
		
	By:	 	 /s/ Jeremy Green

	Name:	 	Jeremy Green
	Title:	 	Managing Member of the Investment Manager
	100 Pine Street, Suite 1925
	San Francisco, CA 94111
	
	REDMILE CAPITAL OFFSHORE FUND II, LTD.
	By:	 	Redmile Group, LLC
	Its:	 	Investment Manager
		
	By:	 	 /s/ Jeremy Green

	Name:	 	Jeremy Green
	Title:	 	Managing Member of the Investment Manager
	100 Pine Street, Suite 1925
	San Francisco, CA 94111

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their
respective authorized officers as of the day and year first above written. 
  

			
	STOCKHOLDERS:
	
	REDMILE SPECIAL OPPORTUNITIES FUND, LTD.
	By:	 	Redmile Group, LLC
	Its:	 	Investment Manager
		
	By:	 	 /s/ Jeremy Green

	Name:	 	Jeremy Green
	Title:	 	Managing Member of the Investment Manager
	100 Pine Street, Suite 1925
	San Francisco, CA 94111
	
	REDMILE PRIVATE INVESTMENTS I, L.P.
	By:	 	Redmile Group, LLC
	Its:	 	Investment Manager
		
	By:	 	 /s/ Jeremy Green

	Name:	 	Jeremy Green
	Title:	 	Managing Member of the Investment Manager
	100 Pine Street, Suite 1925
	San Francisco, CA 94111

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their
respective authorized officers as of the day and year first above written. 
  

			
	STOCKHOLDERS:
	
	  

	 JULIAN HARVEY WOOD
 c/o
Pendragon Capital

	4 Albemarle Street
	London WIS 4GA
	UNITED KINGDOM
	Fax: +44 (0)20 7355 0421
	Email:	 	  

	
	  

	 KAVEH SHEIBANI
 c/o Pendragon
Capital

	4 Albemarle Street
	London W1S 4GA
	UNITED KINGDOM
	Fax: +44 (0)20 7355 0421
	Email:	 	  

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their
respective authorized officers as of the day and year first above written. 
  

			
	STOCKHOLDERS:
	
	PINNACLE VENTURES EQUITY FUND II, L.P.
	PINNACLE VENTURES EQUITY FUND II-O, L.P.
	By:	 	Pinnacle Ventures Equity Management II, L.L.C., their general partner
		
	By:	 	 /s/ Robert N. Savoie

	Name:	 	Robert N. Savoie
	Title:	 	Chief Financial Officer
	
	PINNACLE VENTURES II-A, L.P.
	PINNACLE VENTURES II-B, L.P.
	PINNACLE VENTURES II-C, L.P.
	PINNACLE VENTURES II-R, L.P.
	By:	 	Pinnacle Ventures Management II, L.L.C., their general partner
		
	By:	 	 /s/ Robert N. Savoie

	Name:	 	Robert N. Savoie
	Title:	 	Chief Financial Officer
	
	PINNACLE VENTURES DEBT FUND III-A, L.P.
	PINNACLE VENTURES DEBT FUND III, L.P.
	By:	 	Pinnacle Ventures Management III, L.L.C., their general partner
		
	By:	 	 /s/ Robert N. Savoie

	Name:	 	Robert N. Savoie
	Title:	 	Chief Financial Officer

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their
respective authorized officers as of the day and year first above written. 
  

			
	STOCKHOLDERS:
	
	MPM BIOVENTURES IV-QP, L.P.
	By: 	 	MPM BIOVENTURES IV GP LLC,
	Its:	 	General Partner
		
	By:	 	MPM BIOVENTURES IV LLC,
		 	its Managing Member
		
	By:	 	 /s/ James P. Scopa

	Name:	 	James P. Scopa
	Title:	 	Member
	
	MPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KG
	 By: MPM BIOVENTURES IV GP LLC,
 in
its capacity as the Managing Limited Partner

	By:	 	MPM BIOVENTURES IV LLC,
	Its:	 	Managing Member
		
	By:	 	 /s/ James P. Scopa

	Name:	 	James P. Scopa
	Title:	 	Member
	
	MPM ASSET MANAGEMENT INVESTORS BV4 LLC
	By:	 	MPM BIOVENTURES IV LLC,
	Its:	 	Manager
		
	By:	 	 /s/ James P. Scopa

	Name:	 	James P. Scopa
	Title:	 	Member

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their
respective authorized officers as of the day and year first above written. 
  

			
	STOCKHOLDERS:
	
	NEW ENTERPRISE ASSOCIATES 12, LIMITED PARTNERSHIP
		
	By:	 	NEA Partners 12, Limited Partnership,
	Its:	 	General Partner
	By:	 	NEA 12 GP, LLC,
	Its:	 	General Partner
		
	By:	 	 /s/ Louis S. Citron

	Name:	 	 Louis S. Citron

	Title:	 	 Chief Legal Officer

	
	NEA VENTURES 2008, LIMITED PARTNERSHIP
		
	By:	 	 /s/ Louis S. Citron

	Name:	 	 Louis S. Citron

	Title:	 	 Vice-President

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their
respective authorized officers as of the day and year first above written. 
  

			
	STOCKHOLDERS:
	
	DELPHI VENTURES VII, L.P.
	By:	 	Delphi Management Partners VII, LLC
	Its:	 	General Partner
		
	By:	 	 /s/ Douglas A. Roeder

	Name:	 	Douglas A. Roeder
	Title:	 	Managing Member
	
	DELPHI BIOINVESTMENTS VII, L.P.
	By:	 	Delphi Management Partners VII, LLC
	Its:	 	General Partner
		
	By:	 	 /s/ Douglas A. Roeder

	Name:	 	Douglas A. Roeder
	Title:	 	Managing Member
	
	DELPHI VENTURES VIII, L.P.
	By:	 	Delphi Management Partners VIII, LLC
	Its:	 	General Partner
		
	By:	 	 /s/ Douglas A. Roeder

	Name:	 	Douglas A. Roeder
	Title:	 	Managing Member
	
	DELPHI BIOINVESTMENTS VIII, L.P.
	By:	 	Delphi Management Partners VIII, LLC
	Its:	 	General Partner
		
	By:	 	 /s/ Douglas A. Roeder

	Name:	 	Douglas A. Roeder
	Title:	 	Managing Member

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their
respective authorized officers as of the day and year first above written. 
  

			
	STOCKHOLDERS:
	
	THOMAS WEISEL HEALTHCARE VENTURE PARTNERS, L.P.
	By:	 	Thomas Weisel Healthcare Venture Partners, LLC
	Its:	 	General Partner
	By:	 	Thomas Weisel Capital Management LLC
	Its:	 	Managing Member
		
	By:	 	 /s/ Caley Castelein

	Name:	 	Caley Castelein
	Title:	 	Partner
	
	KEARNY VENTURE PARTNERS, L.P.
	By:	 	Kearny Venture Associates, LLC
	Its:	 	General Partner
		
	By:	 	 /s/ Caley Castelein

	Name:	 	Caley Castelein
	Title:	 	Managing Member
	
	KEARNY VENTURE PARTNERS ENTREPRENEURS FUND, L.P.
	By:	 	Kearny Venture Associates, LLC
	Its:	 	General Partner
		
	By:	 	 /s/ Caley Castelein

	Name:	 	Caley Castelein
	Title:	 	Managing Member

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their
respective authorized officers as of the day and year first above written. 
  

					
	STOCKHOLDERS:
	
	ROCK SPRINGS CAPITAL MASTER FUND LP
	By:	 	Rock Springs GP LLC
	Its:	 	General Partner
			
		 	By:	 	 /s/ Graham McPhail

		 	Name:	 	Graham McPhail
		 	Title:	 	Managing Partner

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their
respective authorized officers as of the day and year first above written. 
  

					
	STOCKHOLDERS:
	
	PERMAL SELECT OPPORTUNITIES LTD.
	By:	 		 	
	Its:	 		 	
			
		 	By:	 	 /s/ Judy Tchou

		 	Name:	 	Judy Tchou
		 	Title:	 	Executive Vice President
	
	PERMAL SELECT OPPORTUNITIES II LTD.
	By:	 		 	
	Its:	 		 	
			
		 	By:	 	 /s/ Judy Tchou

		 	Name:	 	Judy Tchou
		 	Title:	 	Executive Vice President

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their
respective authorized officers as of the day and year first above written. 
  

	
	FOUNDERS
	
	 /s/ Michael Chobotov

	MICHAEL CHOBOTOV
	
	 /s/ Joseph Humphrey

	JOSEPH HUMPHREY
	
	 /s/ Robert Whirley

	ROBERT WHIRLEY

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their
respective authorized officers as of the day and year first above written. 
  

			
	BOSTON SCIENTIFIC SCIMED, INC.
		
	By:	 	  

		 	Name:
		 	Title:
		 	Address:
		 	Facsimile:
		 	E-mail:

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their
respective authorized officers as of the day and year first above written. 
  

			
	STOCKHOLDERS:
	
	  

	MICHAEL T. KELLY
	
	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (DAPER I)
		
	By:	 	 /s/ Martina Poquet

	Name:	 	Martina Poquet
	Title:	 	Managing Director - Separate Investments

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their
respective authorized officers as of the day and year first above written. 
  

	
	STOCKHOLDERS:
	
	 /s/ Peter Justin Klein

	 PETER JUSTIN KLEIN
 c/o New Enterprise
Associates

	5425 Wisconsin Ave., Suite 800
	Chevy Chase, MD 20815
	
	 /s/ John Nehra

	JOHN NEHRA
	1954 Greenspring Drive, Ste 600
	Timonium, MD 21093
	
	 /s/ Cynthia Yee

	CYNTHIA YEE
	
	 /s/ Robert W. Thomas

	ROBERT W. THOMAS
	
	 /s/ John G. Loehr

	JOHN G. LOEHR

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their
respective authorized officers as of the day and year first above written. 
  

			
	STOCKHOLDERS:
	
	 /s/ Raymond P. Haas    /s/ Amanda S. Haas

	RAYMOND P. HASS & AMANDA S. HAAS, AS TRUSTEES OF THE RAYMOND & AMANDA HAAS TRUST, DATED JULY 8, 2004, SCHEDULE B PROPERTY
	
	TAMAPA PARTNERS II
		
	By:	 	 /s/ Taylor Haas Burkhart

	Name:	 	 Taylor Haas Burkhart

	Title:	 	 Partner, Tamapa II

 EXHIBIT A 

PREFERRED STOCKHOLDERS (INCLUDING THE FUNDS) 

FUNDS: 
 Delphi BioInvestments VII, LP 

Delphi Ventures VII, LP 
 Delphi BioInvestments VIII, LP 

Delphi Ventures VIII, LP 
 Kearny Venture Partners Entrepreneurs
Fund, L.P. 
 Kearny Venture Partners, LP 
 MPM Asset Management
Investors BV4 LLC 
 MPM BioVentures IV GmbH & Co. Beteiligungs KG 

MPM BioVentures IV-QP, LP 
 NEA Ventures 2008, Limited Partnership

 New Enterprise Associates 12, Limited Partnership 
 Pinnacle
Ventures Equity Fund II, L.P. 
 Pinnacle Ventures Equity Fund II-O, L.P. 

Pinnacle Ventures II-A, L.P. 
 Pinnacle Ventures II-B, L.P. 

Pinnacle Ventures II-C, L.P. 
 Pinnacle Ventures II-R, L.P. 

Pinnacle Ventures Debt Fund III-A, L.P. 
 Pinnacle Ventures Debt
Fund III, L.P. 
 Thomas Weisel Healthcare Venture Partners, LP. 

Kaiser Permanente Ventures LLC- Series A 
 Kaiser Permanente
Ventures LLC – Series B 
 The Permanente Federation LLC – Series J 

Redmile Capital Fund, LP 
 Redmile Capital Offshore Fund, Ltd.

 Redmile Capital Offshore Fund II, Ltd. 
 Redmile Special
Opportunities Fund, Ltd. 
 Redmile Private Investments I, L.P. 

Deerfield Special Situations Fund, L.P. 
 Deerfield Special
Situations International Master Fund, L.P. 
 Deerfield Private Design Fund II, L.P. 

Deerfield Private Design International II, L.P. 
 Rock Springs
Capital Master Fund LP 
 Permal Select Opportunities Ltd. 

Permal Select Opportunities II Ltd. 

 OTHER PREFERRED STOCKHOLDERS: 

Howard Rice Investment Fund 09 
 John G. Loehr 

John Nehra 
 Julia Vax 

Julian Harvey Wood 
 Kaveh Sheibani 

Michael T. Kelly 
 MPM Investors 

Peter Justin Klein 
 Raymond P.
Haas & Amanda S. Haas, as Trustees of the Raymond & Amanda Haas Trust, Dated July 8, 2004, Schedule B Property 
 Robert W. Thomas

 The Board of Trustees of the Leland Stanford Junior University (DAPER I) 

Tamapa Partners II 
 The Howard Rice Fund 

Thomas A. Magnani 
 Thomas D. Shapiro 

Vladimir & Lydia Chobotov as Community Property 
 Walter
P. Riedel 
 Cynthia Yee 

  
 10 

 EXHIBIT B 

COMMON LEGACY STOCKHOLDERS 
 ABS
Investors, LLC 
 ABS Ventures VI, L.L.C. 
 Allen Meisels 

Asset Management Partners 

Bradford S. Goodwin and Cathy W. Goodwin, as Trustees of the Goodwin Family Trust 1997 U/A/D July 30, 1997 

Craig Urasaki 
 Daniel J. and Suzanne M. Lanahan Living Trust dtd
10/31/2002 
 David E. Farber 
 De Novo (Q) Ventures, I,
L.P. 
 De Novo Ventures, I, L.P. 

Dieter Thurow, Trustee, FBO Thurow Asset Management, Inc. Defined Benefit Pension Plan 

Douglas A. Roeder 
 Edward J. Shapiro 

Franklin P. Johnson, Jr. 
 Geoffrey D. Rubin 

Grady Anderson 
 Graham Keith Crooke 

Harold H. Robinson III Sep. Prop. 
 Harold H. Robinson IV 

Ian Ayton 
 John Bush
Simpson & Rita Lynn Simpson, Trustees of the Simpson Family Trust UDT 1/12/90 
 John M. Harland 

Joseph E. Sweeney, III and Laura S. Sweeney Trust, dated November 11, 2002 

Leonard and Yana W. Goldfine 
 Louis Molinari 

Mahmood K. Razavi 
 Manatuck Hill Scout Fund, L.P. (formerly known
as Pequot Scout Fund, L.P.) 
 Maroney-Bryan Family Trust 

Michael D. Dake, M.D. 
 Michael Malin 

Michael Trokel 
 Pacific Asset Partners 

Philip D. Freedman 
 Raymond P.
Haas and Amanda S. Haas, as Trustees of the Raymond and Amanda Haas Trust, dated July 8, 2004, Schedule A Property 
 Richard Heuser 

Robert H. Andrews 
 Rod White 

Rosecroft LP 
 Sheldon Rubin and
Ann Rubin, Co-Trustees of the Sheldon and Ann Rubin 2004 Revocable Inter-Vivos Trust, dated December 4, 2004 

 Silvestro Conte 

Steven N. Weiss and Mary A. Caldwell 1990 Revocable Trust 
 Teresa
Woodson 
 The Howard Rice Fund 
 The Larry Haimovitch 2000
Separate Property Revocable Trust 
 The Van Ness 1983 Revocable Trust 

Thomas E. Mancino 
 Timothy Doolin 

Valerie P. Betz 
 Vertical Fund I, L.P. 

Vertical Fund II, L.P. 
 William G. Mavity 

  
 ii 

 EXHIBIT C 

ADDITIONAL STOCKHOLDERS 
 Hala Alshahwany

 Jeffrey Austerweil 
 Salvador Balderrama 

Virginia Bicking 
 Monica Boettcher 

James Brady 
 Charis Campbell 

Robert L. Carter 
 Brian Caulfield 

Christopher G. Chavez 
 Gary Chiu 

Michael V. Chobotov 
 Matt G. Condron 

Diane Diaz 
 Teri Driver 

Andrew Duckhorn 
 Rogelio C. Fernandez 

Paola Garnica 
 Joseph German 

Jose Romero-Gonzalez 
 David Goodman 

Therese Gwillim (Myers) 
 Kevin E. Harper 

Jamie Stephen Henderson 
 Vivek Jayaraman 

Stuart P. Kaler 
 Curt Kimble 

Lydia Koroluk 
 Michael R. Kramer 

Sheila Lane 
 Antonio Laudani 

Cheng Li 
 Myriam Luu 

Lexa Mack 
 Michael Maszy 

Timothy Miller 
 Ken Monize 

Robert S. Moore 
 Emilie Munsch 

Robert Padilla 
 Mav Pan 

Ian D. Parsons 
 Carl H. Poppe 

Danielle Powell 

 Ellen S. Pratt 
 Jon
Quilliam 
 Justin Quilliam 
 Walter Riedel 

Anna Rizo 
 Christopher Royston 

Randy Spagnola 
 Anthea Thomas 

James R. Watson 
 Sarah Young 

  
 4 

 EXHIBIT D 

JOINDER TO THIRD AMENDED AND RESTATED STOCKHOLDERS’ AGREEMENT 

This Joinder Agreement (this “Joinder Agreement”) is made as of the date written below by the undersigned (the
“Joining Party”) in accordance with the Fourth Amended and Restated Stockholders’ Agreement dated as of November     , 2013 (as the same may be amended from time to time, the “Stockholders’
Agreement”) by and among TV2 Holding Company and certain Stockholders of the Company and other Persons named therein. Capitalized terms used, but not defined, herein shall have the meaning ascribed to such terms in the Stockholders’
Agreement. 
 The Joining Party hereby acknowledges, agrees and confirms that, by its execution of this Joinder Agreement, the
Joining Party shall be deemed to be a party to the Stockholders’ Agreement as of the date hereof and shall have all of the rights and obligations of a “Stockholder” thereunder as if it had executed the Stockholders’ Agreement.
The Joining Party hereby ratifies, as of the date hereof, and agrees to be bound by, all of the terms, provisions and conditions contained in the Stockholders’ Agreement. 

IN WITNESS WHEREOF, the undersigned has executed this Joinder Agreement as of the date written below. 

Date:                  ,          

 

			
	[NAME OF JOINING PARTY]
		
	By:	 	  

		 	Name:
		 	Title:
	Address for Notices:

  

			
	Facsimile:	 	
	E-mail:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}]]